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ABSTRACT

STRUCTURAL AND FUNCTIONAL ANALYSIS
OF SECONDARY STRUCTURE BLOCK TO mRNA UTILIZATION

by
Juan Lin

Experimentally introduced secondary structure, formed by a cis-targeted
hammerhead ribozyme in exon 2 two nucleotides dowstream of the 3' splice
site of a yeast ACT-E. coli /acZfusion gene, virtually abolishes splicing in vivo
and inhibits B-galactosidase production. This is the first demonstration of the
splicing inhibitory effect of secondary structures occurring in exons in the
absence of splice site sequestration. Our goal is to understand the mechanism
by which utilization of this splice site is impeded. Two cis - and one trans-acting
mutations that alleviate the splicing blockage were obtained by screening for
restoration of B-galactosidase activity. Both cis-acting mutations potentially
destabilize the stem in the region close to the 3' splice site. Combined with the
results from other artificially constructed cis-acting mutants, this finding suggests
that (1) splicing is inhibited by formation of the RNA secondary structures and
(2) the extent of inhibition is directly related to the stablility of the secondary
structures. Our results also indicate that there may be a general phenomenon
of exon 2 secondary structure-specific splicing regulation.
The trans-acting mutation, designated rss1-1, restores B-galactosidase
expression by both increasing the splicing efficiency and stabilizing the

precursor and lariat intermediate. The gene encoding the trans-acting mutant
protein has been cloned. The RSS1 gene is located on Saccharomyces
cerevisiae chromosome V; and is a single copy, essential gene. The predicted

RSS1 amino acid sequence has marked similarity to members of the putative
ATP-dependent RNA helicase family. The trans-acting suppression activity of
rss1-1 is highly allele-specific for the secondary structure of the hammerhead

ribozyme. Different secondary structures, which also block splicing, are not
suppressed by the rss1-1 allele. The single nucleotide change that confers the
rss 1-1 suppresssor phenotype produces a Gly to Arg substitution near the

GRAGR consensus motif. Thus, the GRAGR region might be involved in RNA
substrate interaction. Two alternative models for suppression of the splicing
blockage by rss 1-1 are proposed.
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CHAPTER 1

INTRODUCTION

A. Pre-mRNA splicing

1. The Landmark Discovery

The discovery of pre-mRNA splicing was made two decades ago during
analysis of adenovirus late transcripts (Berget et al., 1977). In these studies,
Philip Sharp and colleagues gel purified the viral mRNA encoding the hexon
polypeptide, a major virion structural protein. To map the region of the viral DNA
encoding this protein, they hybridized hexon mRNA and single-stranded
fragments of viral DNA. The RNA-DNA hybrid was visualized by electron
microscopy. Three loops of single-stranded DNA failed to hydrogen bond to
mRNA. These are the three intron sequences in the adenovirus viral DNA that
are spliced out during the synthesis of mature hexon mRNA. Philip Sharp and
Richard Roberts were awarded the Noble Prize in 1993 for this landmark
discovery.
Soon after the initial discovery of pre-mRNA splicing in adenovirus,
splicing was reported in other viral genomes, rRNA genes, tRNA genes and
chromosomal genes (for reviews see Abelson, 1979; Flint, 1983). RNA splicing
was immediately realized to be a general phenomenon, an essential step in
RNA processing (Abelson, 1979; Flint, 1983).

1

2
2. The Mechanism of Splicing

Within the following few years our understanding of the splicing
mechanism was rapidly advanced, largely due to the development of
mammalian in vitro splicing systems (for review see Green, 1986). The ability to
synthesize abundant unspliced RNA was made possible through efficient
prokaryotic in vitro transcription systems (Kassavetis et al., 1982). A method for
preparing whole-cell extracts (Kole et al., 1982; Padgett et al., 1983) and
nuclear extracts (Hernandez et al., 1983; Krainer et al., 1984) that support the
pre-mRNA splicing reaction was developed. The availability of cell-free extracts,
which could accurately splice exogenous pre-mRNAs in vitro, led to almost
immediate progress in direct characterization of pre-mRNA splicing
intermediates and products. A whole-cell extract from yeast cells that enables
accurate and efficient pre-mRNA splicing was also developed (Lin et al., 1985).
A two-step mechanism of pre-mRNA splicing was then revealed by these
in vitro systems (Fig. 1). All introns within nuclear mRNA precursors are
removed via two successive transesterification reactions (Grabowski et al.,
1984; Padgett et al., 1984; Ruskin et al., 1984; Konarska et al., 1985; Sharp
1987; Moore and Sharp 1993). In the first step, the phosphate at the 5' splice
site is attacked by the 2' hydroxyl group of an internal adenosine residue. This
generates the 5' exon and a branched intron with attached 3' exon, which is
called the lariat intermediate. In the second step, the 3' hydroxyl of the 5' exon
attacks the phosphate at the 3' splice site yielding two products: spliced exons
and the excised lariat intron.

3

Exon 1

A

i
Exon 1

Step 1

Q

i
Exon 1

Exon2

Exon 2

Exon 2

Step2

Q

Figure 1. Two chemical steps of splicing reaction.
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3. ATP-Dependence of Splicing Reaction

It has been known for many years that pre-mRNA splicing requires ATP
hydrolysis (Sawa et al., 1988). Interestingly, there is no net change in the
number of phosphodiester bonds formed or broken in the splicing reaction
(Padgett et al., 1984; Konarska et al., 1985; Lin et al., 1985). ATP hydrolysis is
required in nearly every step of the spliceosome assembly pathway and the two
catalytic steps. These steps include the stable binding of U2 snRNP to the
pre-mRNA (Konarska & Sharp, 1986; Cheng & Abelson, 1987), the binding of
the tripartite U4-U5-U6 snRNPs (Konarska & Sharp, 1987; Cheng & Abelson,
1987), the release of the U4 snRNP just prior to the two chemical steps {Cheng

& Abelson, 1987; Brow & Guthrie, 1988) and the stage just prior to the second
step of splicing (Schwer & Guthrie, 1992).

4. Conserved Sequences At The 5' Splice Sites

The process of RNA splicing requires accurate splice site selection and
cleavage. A major determinant of splice site selection is conserved RNA
sequences at the two splice sites (Fig. 2) (Breathnach et al., 1978). The role of
conserved sequence elements in pre-mRNA splicing was demonstrated by
sequence comparisons of genes and by mutagenesis of the sequence
elements.
A comparison of 5' intron-exon junctions in mammals identified a 5'
splice-junction sequence: AG/GURAGU (/ denotes cleavage site; R is any
purine) (Mount, 1982). The percentage of occurrence of each base at each

5

Mammalian Exon 1

I

AGj GURAGU ---YNYURAC--YAGI Exon 2

l

IExon 1

AGjGUAUGU - - - UACUAAC--CAGI Exon 2

I

yeast

Figure 2. The conserved sequences at the 5' and 3' ss of
mammalian and yeast pre-mRNA. A is any purine. Y is any
pyrimidine. N is any nucleotide. Underlined A is the branch site
residue.

6
position is A64 G 73JG 100u100Aa 2A68G84u63 (Mount, 1982). Mutations at the
almost invariant GU dinucleotide completely inactivate the 5' splice site.
Mutations at other positions have variable effects. For example, mutations at
intron positions 5 and 6 completely inactivate the splice site in adenovirous Ela
pre-mRNA (Solnick, 1981). In contrast, these same mutations do not appear to
inactivate the 5' splice site of the human 8-g,lobin IVS1 gene (Treisman et al.,
1983). Instead, they activate cryptic splice sites (Treisman et al., 1983).
Stronger sequence conservation of the 5' splice site junction is seen in
yeast. The hexanucleotide /GTAYGT (Y is any pyrimidine) is essentially 100%
conserved (Langford and Gallwitz, 1983; Teem et al., 1984). The apparent
difference in degree of conservation between mammals and yeast is reflected in
the behavior of mutations that inactivate the 5' junction. The 5' splice site
mutations seldom activate cryptic splice sites in yeast (as opposed to
metazoans), but lead instead to accumulation of pre-mRNA (Gallwitz, 1982;
Pikielny et al., 1983) or nonproductive, aberrant 5'splice site cleavage products
(Parker & Guthrie, 1985).

5. Conserved Sequences At The 3' Splice Sites

At the 3' end of the intron, three conserved regions are present: branch
site, pyrimidine tract, and 3' splice site (Mount, 1982; Santen & Spritz, 1985).
The branch site consensus is YNYURAC in mammals and UACUAACA in yeast
(N is any nucleotide, underlined A is the branch site residue). A pyrimidine tract
(Yn) is more pronounced and conserved in mammals than in yeast (Reed,
1989; Wieringa et al., 1984). The consensus at the 3' splice site is YAGI in

7
mammals and CAG/ in yeast (Aymond & Rosbash, 1992). Both the 31 splice site
and pyrimidine tract are required for 31 splice site recognition during the second
step of splicing (Vijayraghavan et al., 1986; Fouser & Friesen, 1987; Parker &
Siliciano, 1993; Chanfreau et al., 1994). In yeast, the 3 1 splice site consensus
Y AG is dispensable for the first step of splicing (Aymond & Rosbash, 1985). The
5' splice site cleavage and lariat formation take place in vitro in the absence of
the 3' splice site. In mammals, the CAG 3 1 consensus motif, required in the first
step of splicing, seems to be related to the pyrimidine tract. CAG is required for
5' splice site cleavage and lariat formation in the presence of a short pyrimidine
stretch but is not required if the pyrimidine stretch is long (Reed, 1989).

B. Dynamic RNA-RNA Interactions In the Spliceosome

1. snRNAs

snRNAs are abundant, small(< 300 nucleotides) RNA molecules with
highly phylogenetically conserved sequences (Baserga & Steitz, 1993; Guthrie
& Patterson, 1988). There are five major snRNAs involved in splicing, U1, U2,
U4, US, U6 (for reviews see Steitz et al., 1988; Ruby & Abelson, 1991; Lamond,
1991; Guthrie, 1991 ). All, except U6, are transcribed by RNA polymerase II and
contain a 51 cap structure that is hypermethylated (2, 3, 7-trimethylguanosine)
(Dahlberg & Lund, 1988). U6 is transcribed by RNA polymerase Ill and acquires
a y-methylphosphate cap. All of the five snRNAs localize to the nucleoplasm.
Their secondary structures are well conserved from yeast to man (Baserga &
Steitz, 1993; Reddy & Busch, 1988).

8
snRNAs are complexed with a set of proteins to form ribonucleoprotein
particles, snRNPs (for review see Guthrie, 1991). Some of the proteins are
specific for individual snRNAs. Some are common to most snRNPs. Antisera
from patients with the autoimmune disease systemic lupus erythematosus
contain anti-Sm antibodies targeted against the Sm protein common to U 1, U2,
U4, and U5 snRNPs (Lerner & Steitz, 1979). Isolation of these monoclonal
antibodies has made possible the characterization of the structure and function
of snRNPs.

2. U1 snRNA-pre-mRNA Interaction

The first evidence that snRNAs are involved in splicing was the observed
sequence complementarity of the 5' end of U1 snRNA and the conserved 5'
splice sites of pre-mRNA (Fig. 3) (Lerner et al., 1980; Rogers & Wall, 1980). This
has been subsequently verified biochemically and genetically. U1 snRNA
selectively binds to a pre-mRNA 5' splice site in vitro (Mount et al., 1983).
lmmunoprecipitation of crude nuclear extracts demonstrates that U 1 snRNP is
associated with the pre-mRNA 5' splice site. According to sedimentation
analyses of ribonucleoprotein complexes from mammalian nuclei, at least half
of the wild type U1 snRNPs are associated with the 30S subunit that packages
the high-molecular-weight precursors of pre-mRNAs. In addition, the absence of
a short region of U1 snRNA complementary to 5' splice sites prevents the
association of U1 snRNP with the 30S particles (Lerner et al., 1980). An elegant
genetic experiment demonstrated that introduction of a compensatory
nucleotide change in U1 suppressed a 5' splice site mutation (Zhuang &
Weiner, 1986).
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Figure 3. Interactions at the 5' ss during the course of splicing.
U 1 binds to the 5' ss at a very early step in spliceosome
assembly. It becomes dissociated from the spliceosome. The 5'
ss is recognized a second time and delivered to the catalytic
center of the spliceosome by U6 snRNA.
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Genetic suppression analysis (via compensatory mutagenesis) in the
fission yeast Schizosaccharomyces pombes has suggested that U1 also
interacts with the 3' splice site (Reich et al., 1992). This interaction provides an
attractive means of juxtaposition of 5' and 3' splice junctions early in the
spliceosome assembly. However, only the block to the first step of splicing is
relieved by U1 compensatory mutations. Therefore the 3' splice site must be
recognized by a different factor during the second step of splicing.
Although interaction of U1 snRNA with 5' splice site is required for usage
of the splice site, it is not sufficient to define the exact cleavage site (Seraphin et
al., 1988;Siliciano & Guthrie, 1988; Serahin & Rosbash, 1990). For example,
mutation of the highly conserved G at intron position 5 in yeast often leads to
aberrant cleavages (Parker & guthrie, 1985); however, these aberrant cleavage
reactions are not prevented by compensating base changes in U 1 that restore
base pairing between the mutant 5' splice site and U1 snRNA (Siliciano &
guthrie, 1988; Seraphin et al., 1988). Mutations at intron position 1 (G to A)
allow the step one of the reaction (Newman et al., 1985), yet further processing
of the lariat intermediate is blocked. This blockage is not relieved by introducing
the compensatory base change into U1 snRNA (Siliciano & Guthrie, 1988).
These results suggest that the 5' splice site may be under suNeillance by other
factors after their initial recognition by U1. It is now clear that U1 acts at a very
early step in spliceosome assembly, becomes dissociated from the
spliceosome later on, and is not required for the actual catalytic events
(Crispino & Sharp, 1995; Konforti et al., 1993; Konforti & Konarska, 1994).
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3. U6 snRNA-pre-mRNA Interaction

Compelling evidence demonstrates that the 5' splice site is recognized a
second time during spliceosome assembly and may be delivered to the catalytic
center of the spliceosome by U6 snRNA. Cross-linking experiments indicate
close proximity of U6 with the 5' splice junction (Sontheimer & Steitz, 1993). An
essential region of U6 snRNA forms base pairs with conserved nucleotides at
the 5' splice junction (Fig. 3) ·(Kandels-Lewis & Seraph in, 1993). The functional
interaction of the phylogenetically invariant ACAGAG sequence in U6 snRNA
with the 5' splice site has been proven by genetic suppression (Kandels-Lewis

& Seraphin, 1993; Lesser & Guthrie, 1993). Compensatory mutations, predicted
to stabilize the interaction, increase normal cleavage and suppress aberrant
cleavage resulting from a mutation in the conserved G at yeast intron position 5.
Interestingly, the invariant ACAGAG sequence is immediately adjacent to
sequences in U6 that base pair with U2 snRNA (Fig. 6). This proximity allows
alignment of the 5' splice site with the branch site and subsequent nucleophilic
attack by the branch point residue (Madhani & Guthrie, 1994).
An in vitro synthesized RNA oligo nucleotide, which contains a
consensus 5' splice site, has been shown to specifically bind to the U4/U5/U6
snRNA complex (Konforti & Konarska, 1994). Unlike the interaction with U1
snRNA, this recognition seems to depend largely on interactions other than
RNA-RNA base pairing. The 5' splice site-U4/U5/U6 snRNP complex is
proposed to be an intermediate in spliceosome assembly. The intermediate
appears after the 5 1 splice site-U1 snRNA base pairing is disrupted but before
the U4-U5 interaction is destabilized.
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4. U2 snRNA-pre-mRNA Interaction

The essential role of the U2 snRNP in pre-mRNA splicing was
established by demonstrating that extracts depleted of U2 snRNP were deficient
in splicing. U2 snRNA interacts with the branch point consensus to form a short
helix which bulges out the branch site A residue (Fig. 4) (Parker et al., 1987;
Query et al., 1994; Wu & Manley, 1989; Zhuang & Weiner, 1989). Base pairing
interaction between U2 snRNA and the branch point region has been
substantiated by compensatory mutations in both yeast and mammals (Parker
et al., 1987; Wu & Manley, 1989; Zhuang & Weiner, 1989).
Binding of U2 snRNA to the branch point requires multiple protein factors
(eg., U2AF, U1 snRNP) and ATP (Brosi et al., 1993; Ruskin et al., 1988; Zamore
et al., 1992; Zamore & Green, 1989). A conformational change, mediated by
helicase-like splicing factor(s), might be necessary for efficient assembly of U2
snRNA into the spliceosome (Ruby et al., 1993). The question of how this might
help the association of U2 with the pre-mRNA remains to be addressed.

5. US snRNA-pre-mRNA Interaction

US snRNA contains a highly conserved single-stranded loop sequence
that includes the invariant nine nucleotide motif (Patterson & Guthrie, 1987).
Specific mutations in this loop can have striking effects on the specificity of
S'splice site cleavage in pre-mRNAs with mutations at intron position 1 (G to A)
(Newman & Norman, 1991 ). They either activate new 5' splice sites in the
vicinity of the authentic site or facilitate processing of dead-end lariat
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Figure 4. Interaction of the branch point region with U2
snRNA. The branch site A residue is bulged out.

US snRNA

Figure S. US snRNA/pre-mRNA interaction. The invariant
loop sequence of US can base pair with nucleotides in exon
1 or the first two bases of exon 2. This interaction persists
through both steps of splicing. US may serve to anchor the
excised exon 1 after the first step of splicing and help allign
the nucleophile for the second catalytic step. Site of
nucleophilic attack on the 3' ss is shown as arrow. Adapted
from Science 262.1978-1979.
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intermediates to mRNA. This is achieved by the invariant US snRNA loop base
pairing with nucleotides upstream of the cleavage site or with the first two bases
of exon 2, respectively (Fig. S) (Newman & Norman, 1992). Cross-linking
experiments suggest: (1) the contact between US and exon 1 persists through
both steps of splicing and (2) the first residue of exon 2 becomes crosslinked to
US after the first step of splicing (Sontheimer & Steitz, 1993). Taken together,
these data strongly suggest that US snRNA serves to anchor the excised exon 1
within the spliceosome following the first step of splicing and help align the
nucleophile for the second catalytic step.

6. U4·U6 Helix

Base pairing between U4 and U6 is probably the best characterized
intermolecular snRNA-snRNA interaction. The interaction is strongly supported
by phylogenetic studies (Brow & Guthrie, 1988) and has been demonstrated in
several experimental systems (Brow & Guthrie, 1988; Hashimoto & Steitz, 1984;
Rinke et al., 198S). Some mutations in U6 snRNA cannot be complemented by
compensatory mutations in U4 snRNA (Madhani et al., 1990; Vankan et al.,
1990). This is due to additional roles for U6 nucleotides. After U4/US/U6 enters
the spliceosome as a tri-snRNP, the extensive base pairing between U4 and U6
is disrupted and replaced with a U2-U6 intermolecular interaction (part of the
catalytic core of the spliceosome) (Lamond et al., 1988;

Yea~

& Un, 1991). U4

then dissociates from the spliceosome and does not participate further in the
splicing reaction (Yean & Lin, 1991). Thus, U4 snRNA functions to deliver U6
and prevent undesired U6 catalysis until the appropriate time.
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7. U2-U6 Helices

U2/U6 sNRNAs are thought to comprise part of the catalytic core of the
spliceosome (Madhani & Guthrie, 1994b; Nilsen, 1994). Several base-pairing
interactions, helices la, lb, and II (Fig. 6), have been proposed between U2 and
U6 snRNAs (Madhani & Guthrie, 1992; Weiner 1993, Sun & Manley, 1995).
The U2-U6 helix I was originally identified in yeast {Madhani & Guthrie,
1992). It is composed of helix la, a two nucleotide bulge, and helix lb. Helix I
exhibits extraordinary phylogenetic conservation, not only of the secondary
structure but also of primary RNA sequences. Biochemical analysis shows that
the integrity of this helix is required for efficient splicing in vivo. Formation of
U2-U6 helix 1 has been confirmed genetically in yeast by showing that
mutations in one pairing partner can be suppressed by a compensatory base
change in the other. However, incomplete suppression is almost never
complete, especially for certain mutations in U6, suggests additional essential
roles for U6 nucleotides. U6 is the most conserved snRNA in terms of size and
primary sequences (Baserga & Steitz, 1993). The formation of helix I could
bring together the invariant ACAGAG sequences in the central domain of U6
with sequences in U2 that lie immediately upstream of the branch point (Fig. 6).
The ACAGAG sequences, which are potential catalytic residues of U6, can then
be closely juxtaposed with the branch point and 5' splice site, which in turn, is
recognized by U6. This provides an attractive structural basis for the
spliceosomal active site (Madhani & Guthrie, 1994b).
Helix II was discovered through psoralen crosslinking experiments in
human cell extracts (Hausner et al., 1990). The ability to form helix II is
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Figure 6. U2/U6 snRNA helices. Formation of helix la brings together
the invariant ACAGAG sequences (shaded) in U6 with the consensus
AUGAUG sequences (shaded) in U2 together. ACAGAG interacts with
the 5' ss. AUGAUG interacts with the branch point. This would position
the U2-U6 structure (putative catalytic core) near both the 5' ss and the
branch point, therefore providing an attractive structural basis for the
spliceosomal active site.
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conserved in all eukaryotic species, although the primary sequences are not.
Mutations disrupting the formation of helix II result in splicing defects in Hela
cells (Detta & Weiner, 1991; Wu & Manley, 1991). In Hela cells, helix II has been
directly demonstrated by allele specific suppression (Detta & Weiner, 1991; Wu

& Manley, 1991 ). In contrast to the observations with its mammalian
counterparts, helix II does not appear to be esssential for yeast (Madhani et al.,
1990; Madhani & Guthrie, 1994a). Deletion of almost all of the U6 or U2
nucleotides proposed to form helix II results in only a slightly cold-sensitive
phenotype. The discrepancy between yeast and mammals can be explained by
functionally redundant U2-U6 interactions in yeast (Field & Friesen, 1996).

C. Effect of Secondary Structure on Pre-mRNA Splicing

1. In The Presence of Splice Site Sequestration

Pre-mRNA secondary structure has a significant influence on splice site
selection and splicing efficiency. A naturally occurring pre-mRNA secondary
structure sequesters the proximal 3' splice site of the budding yeast
Kluyveromyces lactis actin intron and is required for activation of the distal
3' splice site (Deshler & Rossi, 1991 ). Regulation of the splicing of ribosomal
protein RPL32 pre-mRNA in Saccharomyces cerevisiae, may depend on the
formation of a stem-loop structure which includes the 5' splice site (Eng &
Warner , 1991 ). Experimentally introduced hairpins, which sequester the
5' splice site or branch point region, strongly inhibit splicing in yeast, both in
vivo and in vitro (Yoshimatsu & Nagawa, 1989; Goguel et al., 1993).
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The inhibitory effect of hairpins, which sequester the 5' splice site, has
also been observed in the dicot plant Nicotiana plumbaginifolia (Goodall &
Fillipowicz, 1991; Liu et al., 199S). In mammalian systems, secondary structure
can strongly influence the selection of alternative splice sites, regulating
formation of multiple mRNAs from the same transcript (Libri et al., 1991; Solnick
1985; Watakabe et al., 1989).

2. In The Absence of Splice Site Sequestration

Few studies have examined the effect of secondary structures occuring in
exons, in the absence of splice site sequestration, on splicing. Dominski & Kole
(1994) have used antisense 2'-0-methyl oligoribonucleotides to block a number
of sequences in human B-globin pre-mRNA. They demonstrated that at least
2S nucleotides of B-globin exon 2 sequences are required for splicing.

us

snRNA is one of the snRNAs likely to be affected by secondary structure in exon
2 adjacent to the 3' splice site. The conserved US snRNA loop sequence has
been shown to base pair with exon sequences adjacent to S' and 3' splice sites
(Newman & Norman, 1992; Wyatt et al., 1992; Sontheimer & Steitz, 1993;
Newman et al., 199S). It is possible that single-stranded exon regions at S' and
3' splice sites are required for the effective involvement of US snRNA. Cellular
proteins that interact with the 3' splice site may also be displaced. Introduction
of secondary structure close to a 3' splice site could sterically hinder the access
of trans-acting proteins to the 3' splice site. Among these factors are Slu7 and
Prp8, which have previously been shown to promote 3' splice site recognition in
the yeast Saccharomyces cerevisiae (Frank & Guthrie, 1992; Umen & Guthrie,
199Sa; Umen & Guthrie, 199Sb).
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D. Identification of Splicing Factors in Yeast

1. Why Yeast?

Following the demonstration of yeast pre-mRNA splicing in the early 80 1s
(Domdey et al., 1984; Newman et al., 1985; Lin et al., 1985), detailed analyses
of transcripts in yeast showed the strikingly identical lariat intermediate both in
vivo and in vitro. The 51 end of the intron is joined by a 2'-5' phosphodiester
· bond to a site within the intron. These results argued that yeast and mammals
share fundamental similarities in pre-mRNA splicing. Because of the ease of
combining genetic and biochemical analyses, Saccharomyces cerevisiae has
since become an invaluable source of information on pre-mRNA splicing.

2. Isolation of rna (prp) Mutants

The first splicing factors in yeast were initially isolated in a screen for
temperature sensitive mutants defective in the synthesis of macromolecules
(Hartwell, 1967). Several of these mutants (rna2 to ma11) were later shown to
have defects in splicing and to accumulate pre-mRNAs in vivo (Woolford, 1989;
Warner JR, 1987). They were subsequently renamed pre-RNA processing (prp)
mutants.
Additional PAP genes have been isolated in screens of new sets of
. temperature-sensitive mutants defective in RNA splicing or as second-site
suppressors of mutations in spliceosomal components (for reviews see Guthrie
1991; Ruby & Abelson, 1991; Aymond & Rosbash, 1992). Unlike the prp2-prp 11

20
mutants, which accumulate pre-mRNA, some of the additional prp mutants
have novel phenotypes. For example, some accumulate the lariat intermediate
or the excised intron, indicating their role in late stages of splicing. At present,
some 30 PAP proteins have been identified.
Yeast PAP proteins affecting splicing can be separated into two classes:
snRNPs or non-snRNA protein splicing factors (Guthrie, 1991). The snRNPs are
sometimes referred to as integral proteins. They bind tightly to one or more
species of snRNA and can be co-immunoprecipitated with snRNA(s). The
non-snRNP proteins are loosely associated with snRNAs and sometimes
appear to interact transiently with the spliceosome.

E. Yeast Helicase-like Splicing Factors

Many of the PAP genes have been cloned and sequenced (Guthrie
1991; Moore et al., 1993; Ruby & Abelson, 1991; Aymond & Rosbash, 1992).
Sequence analysis has identified an exciting group of yeast PAP genes that
belong to a family of ATP-dependent RNA helicases (Ruby & Abelson, 1991;
Fuller-Pace, 1994)). These proteins are mainly classified into three subgroups:
DEAD, DEAH or DEXH-box proteins (according to the differences in the
conserved protein motifs) (for reviews see Wassarmann & Steitz, 1991; Schmid

& Linder, 1992). PRP2, PRP16, and PRP22 are DEAH-box proteins. PAPS and
PAPS are DEAD-box proteins. The identiication of the splicing factors
resembling RNA helicases helps to explain the question posed earlier (section
1.A.3): why is ATP required in the splicing reaction? These putative PAP
ATP-dependent helicases would require ATP to unwind duplex RNA during
pre-mRNA splicing.
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1. PRPS

PRP5 acts before the two catalytic steps of the splicing reaction {Fig. 7). It
interacts with three other yeast spliceosomal proteins {PRP9, PRP11 and
PRP21) to promote U2 snRNP binding to pre-mRNA {Ruby et al., 1993; Wells &
Manuel Ares, 1994). Functional interaction between U2 snRNA and PAPS,
PRP9, PRP11 and PRP21 has been suggested by synthetic lethality {Wells &
Manuel Ares, 1994). Many synthetic lethal U2 mutations lie in highly conserved
or invariant RNA structures, suggesting that the conserved U2 elements are
required for efficient cooperative function with PAPS, PRP9, PRP11 and PRP21.
The stable binding of U2 snRNP to the spliceosome is dependent upon
ATP (Konarska & Sharp, 1987; Cheng & Abelson, 1987). The helicase-like
PAPS may mediate a conformational change that is required for the association
of U2 snRNP with pre-mRNA.

2. PRP28

A cold-sensitive mutant, prp28, inhibits the first step of mRNA splicing
(Strauss & Guthrie, 1991 ). The cold sensitivity is caused by a single mutation in
a conserved helicase motif. Two pieces of genetic evidence suggest that PRP28
is functionally associated with the U4/US/U6 snRNP (Strauss & Guthrie, 1991 ).
First, double mutants containing conditional alleles of PRP28 and PRP24, a U6
snRNA-binding protein, exhibit synthetic lethality. Second, a suppressor of

prp28-1 is a mutant allele of PAPS {a US snRNA-binding protein). Since U4 and
U6 are normally held together by extensive intermolecular base pairs (Brow &
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Figure 7. The roles of five yeast
PRP proteins in pre-mRNA
splicing. Open box, exon 1; black
box, exon 2; thin line, intron.
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Guthrie, 1988; Hashimoto & Steitz, 1984; Rinke et al., 1985), dissociation of
U4from the spliceosome and subsequent U2-U6 base pairing is likely to be
energy-dependent and require the action of an ATP-dependent RNA helicase.

3. PRP2

PRP2 interacts transiently with spliceosomal complexes prior to and
during step one of the splicing reaction (King & Beggs, 1990).
lmmunoprecipitation established that PRP2 co-precipitated with pre-mRNA and
splicing intermediates, but not with the spliced products.

PRP2 is required for the first catalytic step of the splicing reaction (Lin et
al., 1987). ATP hydrolysis is required at this step (Kim & Lin, 1993).The purified
PRP2 protein has been demonstrated to have an RNA-dependent NTPase in
vitro (Kim et al., 1992). PRP2 is postulated to bind to the spliceosome, hydrolyze
ATP, induce a conformational change within the spliceosome, and allow
splicing to proceed.

4. PRP16

PRP 16was first identified from a dominant mutant, prp16-1, that
suppresses the deficiency of splicing of a mutant gene containing a branchpoint
muation (A to C) (Couto et al., 1987). The prp16-1 allele contains a single
nucleotide change near the conserved ATP-binding motif (Burgess et al., 1990).
Additional prp16 alleles suppressing the branchpoint mutation were
subsequently identified and all the suppressor mutations map near or within the
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ATP-binding motif (Burgess & Guthrie, 1993). Not surprisingly, all suppressor
mutations reduce ATPase activity in vitro (Schwer & Guthrie, 1992; Burgess &
Guthrie, 1993). In vivo RNA analysis indicates that prp16 suppressor alleles
increase the steady-state level of lariat intermediates (Burgess & Guthrie, 1993).
These lariat intermediates that would otherwise have been degraded can be
utilized. A model has been proposed in which decreased ATPase activity is
coupled to a relaxation in fidelity (Burgess & Guthrie, 1993). ATP hydrolysis
activates a discard pathway. Slowing the rate of ATP hydrolysis allows incorrect
. intermediates more time to proceed through the productive splicing pathway
and results in decreased fidelity.

PRP 16 is required for step two of the splicing reaction in vitro (Schwer &
Guthrie, 1991 ). PRP16 is a non-snRNP protein that associates tightly with the
spliceosomes that have completed 5' splice site cleavage and lariat formation. It
then hydrolyses ATP and releases itself from the spliceosome (Schwer &
Guthrie, 1991). Stalled spliceosomes, pre-formed in a PRP16 immunodepleted
extract, can be complemented with the purified PRP16 protein and ATP to yield
mature mRNA (Schwer & Guthrie, 1991). The binding site of PRP16 in the
spliceosome may be the 3' splice site (Umen & Guthrie, 1995a; Umen &
Guthrie, 1995b). PRP16 is thought to have two possible functions: (1) bringing a
potential 3' splice site into the spliceosomal active site or (2) mediating a
conformational change that is required for the second step of splicing.
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5. PRP22

The PRP22 gene is not essential for either spliceosome assembly or
both steps of splicing (Company et al., 1991 ). However, it is required for the
release of the mRNA product from spliceosomes (Company et al., 1991 ). Heat
inactivated splicing extracts prepared form prp22 mutants retain both mature,
spliced mRNA, and excised lariat intron in the spliceosome. The first human
RNA helicase-like splicing factor, HRH1, which is highly homologous to PRP22,
has been identified (Ohno et al., 1994). Expression of HRH1 in a yeast prp22
mutant partially rescues the temperature-sensitive phenotype. A dominantnegative HRH1 protein stalls on the spliceosome and prevents release of the
spliced RNA from the spliceosome.

F. ATP-Dependent RNA Helicases

1. Conserved Elements

All of the putative RNA helicases show a considerable degree of amino
acid sequence homology. The core region of about 380 amino acids contains
several domains of conserved peptide sequence and relative spacing (Fig. 8)
(Gorbalenya et al., 1988, Gorbalenya et al., 1989). The most characteristic
sequence element of putative RNA helicases is the ATP-binding domain. The
conserved sequence AXXGXGKT has been previously described as the A motif
of ATPases (Saraste et al., 1990; Walker et al., 1982). The B motif of ATPases
contains a DE sequence which is highly conserved and almost invariant in
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Figure 8. Schematic of the highly conserved motifs in putative RNA
helicases. Depending upon the two amino acids following DE, putative
RNA helicases are subgrouped into DEAD, DEAH or DEXH proteins.
Adapted from Fuller-Pace, 1994.
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putative RNA helicases (Walker et al., 1982). Depending upon the two amino
acids following DE, putative RNA helicases are subgrouped into DEAD, DEAH
or DEXH proteins (Fuller-Pace, 1994; Schmid & Linder, 1992). The motifs SAT
and GRAGR are also conserved within the family of ATP-dependent RNA
helicases (Gorbalenya et al., 1988 & Gorbalenya et al., 1989). The central core
region is usually flanked by amino- and carboxyl-terminal residues of unique
sequence which are thought to provide specifity to the functions of individual
helicases.

2. The Function of The Conserved Motifs

Understanding the roles of the conserved motifs in putative RNA
helicases has been greatly facilitated through extensive mutational analyses.
Dominant mutations of prp16 alleles that suppress the mutated branch site all
map to the ATPase domain and cause reduced ATPase activity in vitro (Schwer

& Guthrie, 1992; Burgess & Guthrie, 1993). A systemic study of elF-4A shows
that GXGKT motif is required for ATP binding and consequently ATP hydrolysis
and RNA unwinding (Pause & Sonenberg, 1992). The DEAD motif in elF-4A is
critical for ATP hydrolysis and consequently for RNA helicase activity, but not for
ATP binding (Pause & Sonenberg, 1992). The SAT motif in elF-4A is
dispensable for ATP binding and hydrolysis but essential for RNA helicase
activity (Pause & Sonenberg, 1992). Mutations in the HRIGRXXR sequence
drastically reduce elF4A cross-linking to RNA and abrogate RNA helicase
activity (Pause et al., 1993). Some of those mutations also affect ATP binding
and ATPase activity, suggesting a coupling of ATP hydrolysis and RNA
unwinding.
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3. Diverse Array of Cellular Functions Involved

Many proteins have been identified in the family of putative
ATP-dependent RNA helicases. They are isolated from organisms ranging from
bacteria (E. coli) to man (H. sapiens) ( for review see Fuller-Pace, 1994;
Schmid & Linder; 1992; Wassarman & Steitz; 1991). They are involved in
multiple steps of RNA metabolism, which include RNA splicing, ribosome
assembly, translation, initiation, RNA localization, RNA stability,
spermatogenesis, embryogenesis, and cell growth and division. Five yeast PRP
proteins, PrpS, 28, 2, 16, and 22, participate in pre-mRNA splicing (Schmid &
Linder, 1992). Their identification has helped to decipher the highly dynamic
and ATP-consuming process of splicing. The elF4A protein is believed to use
the energy generated from ATP hydrolysis to unwind RNA secondary structure,
to allowing the 40S ribosomal initiation complex to bind and scan for the
initiation AUG codon (Abramson et al., 1987; Grifo et al., 1984; Linder et al.,
1989; Rozen et al., 1990). The SrmB and DeaD proteins from E.coli are
thought to be required for ribosomal subunit assembly (Nishi etal., 1988; Toone
et al., 1991 ). The Drosophila gene products Vasa and His are necessary for
RNA localization in oogenesis (Lasko & Ashburner, 1988; Gillespie & Berg,
1995). Recently, the DEAD/DEAH box RNA helicases have been implicated in
RNA stability. Overexpression of the SrmB and Dead proteins has been shown
to promote mRNA stability in E. coli (lost & Dreyfus, 1994). The Prp16 protein is
proposed to control a discard pathway for aberrant lariat intermediates and the
suppressor alleles of PRP16 were shown to stabilize lariat intermediates
(Burgess & Guthrie, 1993).
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4. Biochemical Activities

Although putative RNA helicases have diverse cellular functions, there is
one common theme among them. They are all thought to have similar
biochemical activity and function through modulation of RNA structures
(Fuller-Pace, 1994). Many of them have been demonstrated to possess an
RNA-dependent ATPase activity (Fuller-Pace, 1994). Yet only a few (for
example, elF-4A, p68 and Xenopus An3) exhibit an RNA helicase activity in
vitro (Gururajan et al., 1994; Hirling et al., 1989; Rozen et al., 1990). This may·
be due to specificity of the RNA substrate or the reaction condition.

G. Objectives

Numerous studies have focused upon the inhibition of splicing by
hairpins (stem-loop structures) that sequester splice sites. Very few studies,
however, have examined the inhibitory effect of secondary structures occurring
in exons in the absence of splice site sequestration. We have inserted a
cis-targeted hammerhead ribozyme encoding sequence, 5 nucleotides (nt)

downstream of the actin 3' splice site in a yeast ACT-E. coli lacZfusion gene. It
should be noted that the ribozyme does not cleave in yeast. We were simply
utilizing the ability of the ribozyme sequence to form a stem-loop secondary
structure. The ribozyme secondary structure occurs in exon 2 without
sequestering the 3' splice site per se. The ribozyme sequence introduced in the
pre-mRNA virtually abolishes splicing in vivo and inhibits expression of the
ACT-/acZfusion protein in yeast. The mechanism by which the ribozyme
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impedes splicing was not known. Thus, we decided to isolate both cis - and
trans -acting mutants that suppress this splicing blockage.

For the cis acting mutants, our goal was to identify the element that
blocks normal pre-mRNA splicing. We sought to determine whether it is the
primary sequence or secondary structure of the ribozyme which blocks splicing.
If it is the secondary structure, then we sought to determine whether other RNA
secondary structures in exon 2 also block splicing. Finally, we wished to
determine whether the extent of splicing inhibition correlates with the stability of
RNA secondary structure.
For the trans acting mutants, our goal was to identify a protein factor
involved in splicing. The spliceosome is a very complex machinery, with many
identified proteins, and yet to be identified factors, participating in splicing.
Identification of new splicing factors should help elucidate the complex process
of pre-mRNA splicing. Our strategy for isolating a potentially new splicing factor
was to look for mutations which suppressed the splicing blockage conferred by
the hammerhead ribozyme 3' splice site to be used. An RNA helicase-like
splicing factor with altered helicase specificity or higher than normal helicase
activity was a possible candidate. Such a mutant helicase would be able to
unwind the secondary structure of the hammerhead ribozyme, thereby allowing
normal splicing of the pre-mRNA to take place.
Achieving these goals has produced one published paper (Chapter 3)
and several unpublished experiments which extend the paper's findings
(Chapter 4). In addition, two additional strategies to identify HIV-1 RNA (CRS,
INS-1, and TAR elements)-protein interactions required for HIV-1 gene
expression are included in this dissertation (Chapter 6). When these strategies
did not achieve their objectives, the project described above was initiated.

CHAPTER 2

MATERIALS AND METHODS

A. Materials

1. S. cerevisiae and E. coli strains

J M43 (MATa /eu2-3, 112 ura3-52 trp 1-289 his4-580) was kindly provided
by Dr. Joan McEwen (Beckman Research Institute of City of Hope, Duarte, CA).
It was used in the genetic screen for isolating cis- and trans-suppressors that
could restore B-galactosidase expression. One of the two temperature sensitive
trans-suppressors isolated was crossed with JM19 (MATa ade his4-580) (also
kindly provided by Dr. Joan McEwen) and the resulting diploids were
sporulated. A temperature sensitive haploid from this sporulation was
backcrossed three times with JM43 to obtain JL2 (MAT trp1-289 ura3-52
his4-580 rss 1-1 ).
E. coli XL 1-Blue supE44 hsdR 17 (rk-, mk+) recA 1 endA 1 gyrA96re/A1
lac- F' [ proAB+ /ac/q lacZ1M 15 Tn 1O(tet r)] was used for propagating yeast

shuttle vectors and for the isolation of DNA for subcloing and yeast
transformations.
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2. Growth Media

All yeast strains were grown in either YPD or CSM minus (CSM-) media.
YPD liquid medium contains 1% yeast extract (w/v), 2% peptone (w/v), and 2%
dextrose (w/v). CSM minus dropout liquid medium contains 0.17% YNB-AA/AS
(w/v), 0.5% (NH4)2S04 (w/v), and 2% dextrose (w/v). Sporulation liquid
medium contains 1% potassium acetate (w/v), 0.1 % yeast extract (w/v), and
0.05% dextrose (w/v). YPD, CSM-, and sporulation plates have 2% agar (w/v)
added. E. coli strains were grown in LB media, which contained 1% bacto
trypton (w/v), 0.5% yeast extract (w/v), 0.5% NaCl (w/v), and 0.1 % dextrose
(w/v).

3. Enzymes

Restriction enzymes were obtained from Boehringer Mannheim
(Indianapolis, IN), New England Biolabs (Beverly, MA), and Promega Corp.
(Madison, WI). T 4 DNA ligase was obtained from Boehringer Mannheim
(Indianapolis, IN) and New England Biolabs (Beverly, MA). AMV reverse
transcriptase was obtained from Promega Corp. (Madison, WI). Taq DNA
polymerase was obtained from Perkin-Elmer Cetus (Norwalk, CN). Zymolyase
1OOT was obtained from Seikagoku Kogyo Co (Tokyo, Japan). Glusulase was
obtained from Sigma Chemical Co. (St. Louis, MO).
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4. Chemicals

[y-32P]ATP and [a-32P]dCTP were obtained from Amersham Life
Science Inc. (Arlington Heights, IL). Unlabeled deoxynucleotides were
obtained from Life Technologies Inc. (Gaithersburg, MD). All other chemicals
were molecular biology grade and were obtained from Sigma Chemical Co.
(St. Louis, MO) or Fisher Scientific Co. (Irvine, CA).

5. Plasmid Constructs

The mutations in artificially constructed cis-acting mutants were created
by polymerase chain reaction (PCR) amplification of the pJYH7-mrz DNA using
primers that contained the desired nucleotide changes. The PCRs were
conducted in a Perkin-Elmer/Cetus DNA thermal cycler (using the strandard
reaction mixtures suggested by the manufacturer). A stepped-cycle program
was used: 30 cycles of 1 min at 94°C, 1 min at 55°C, and 1 min at 72°C. The
amplified PCR products were digested with Sal I, then ligated with Sal I
linearized pJYH7 vector DNA.

B. Methods

1. Mutagenesis of Yeast Cells

Mutagenesis of yeast cells was performed according to the method of
Winston (1993). Five milliliters of overnight culture of Sacharomyces cerevisiae
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strain JM43 transformed with plasmid pJYH7-mrz was grown at 30°C. The
concentration of cells was adjusted to approximately 2 x 108 cells/ml (according
to an estimate of cell number at 00600 ). Cells were pelleted in a
microcentrifuge, the pellet resupended in 1 ml sterile water, and washed twice.
After the second wash, the cells were resuspended in 1.5 ml sterile 0.1 M
sodium phosphate buffer, pH 7.0. Next 0.7 ml cell suspension was added to
1 ml 0.1 M sodium phosphate buffer in a 13 x 100-mm sterile polypropylene
tube. EMS was added to 1 ml aliquots of cells (different amounts to determine
the optimal concentration for mutagenesis: EMS treatment should cause about
40% of the cells to be killed for optimal mutagenesis). Treated cell suspension
(0.2 ml) was transfered to a tube containing 8 ml of sterile 5% sodium
thiosulfate, to stop mutagenesis by inactivation of EMS. Mutagenized cells
(0.1 ml) were plated on CSM minus uracil agar plates. As a control, 0.1 ml of
nonmutagenized cells were also plated. The percentage of cells killed by EMS
treatment was calculated. The level of EMS that resulted in about 40% killing
(i.e. 60% survival) was used for mutagenesis.

2. Tetrad Analysis

Tetrad analysis was performed according to the method of Treco &
Winston (1993). Diploids were constructed by mating strains of opposite mating
types (a and a) on the surface of agar plates. Cells from freshly grown streaks
of each haploid parent were mixed together on YPD agar plates that allow
growth of both haploid strains. The mating was allowed to proceed for at least
4 hours at 30°C. The mixtures were replica-plated onto CSM- agar plates that
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select for the diploid genotype. The diploids cells were grown freshly on YPD
agar media before being patched onto a sporulation plate. After 3-5 days at
30°C, tetrads were visualized by a light microscopy of a suspension of yeast in
a drop of water on a microscope slide. To prepare yeast tetrads for dissection,
sporulated tetrads was suspended in 100 µI of diluted glusulase in a 1.5-ml
m icrocentrifuge tube. The tube was vortexed vigorously and incubated at 37°C
for 5-30 minutes. The glusulase treatment was considered complete when
approximately half the tetrads showed disruption of their ascus walls. The four
spores should remain associated, but more loosely than when initially
examined. The wall of the ascus should be expanded and loosely associated
with the spores. Sterile water (0.8 ml) was gently added, by slowly dripping it
down the inside of tube. The tube was set on ice. Glusulase-treated spores
were streaked in two parallel Hnes·across the surface of a YPD plate. The plate
was inverted (with the lid off) under a dissecting microscope. Individual spores
were then dissected from tetrads and placed in a row for further analysis.

3. Yeast Transformation

Yeast transformation was performed according to the methods of
Hill et al., {1991 ). A single yeast colony was inoculated into 2-3 ml YPD broth
and grown with aeration at 30°C overnight. The following morning, about
100 µI of the overnight culture was inoculated into 1O ml YPD broth. Cells were
grown at 30°C with shaking until 00600 reached 0.5-0.7. Cells were then
centrifuged at 3000g for 15 minutes at 4°C. The pellet was washed in 1ml of
LiOAc solution (0.1 M LiOAc, 10 mM Tris HCI (pH 8.0), 1 mM EDTA]. The
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suspension was centrifuged as before, then resuspended by adding 0.1 ml of
LiOAc solution and gently shaken by hand. Yeast suspension (0.1 ml) was
added to a 1.5 ml centrifuge tube containing 10 µI of transforming DNA. The
contents were mixed gently then left at room temperature for 5 minutes. Next
280 µI of PEG4000 solution (50% PEG4ooo in LiOAc solution) was added. The
contents were mixed by inverting the tubes 4-6 times. The tube was placed at
30°C for 45 minutes without shaking. Next 43 µI DMSO was added to creat an
approximate 10% (v/v) DMSO solution in tube. The contents were mixed by
inversion, then heat-shocked at 42°C for 5 minutes. For temperature sensitive
yeast strains, the heat shock temperature was 37°C. Cells were then
centrufuged at 12000g for 30 seconds and resuspended in 1 ml dH 2 0. About
200 µI of transformed cells were spread on CSM- media.

4. Assaay for J3-galactosidase In Liquid Cultures

The quantitative assay of J3-galactosidase activity in liquid yeast cultures
was performed according to the method of Reynolds & Lundblad (1987). A
single yeast colony containing the lacZ fusion protein was inoculated into 5 ml
of CSM minus uracil medium and grown overnight at 30°C. Approximately
50-100 µI of the overnight culture was inoculated into 5 ml CSM minus medium
and grown until 00 600 reached 0.5-0.8. The cells were centrifuged 5 minutes
at 3000g in a tabletop centrifuge and the pellets were resuspended in Z buffer
and placed on ice. The 0060 0 was determined for each sample. Three
replicate reaction tubes were prepared for each sample: 100 µI cells with 900 µI
Z buffer (60 mM Na2HP04, 40 mM NaH2P04, 10 mM KCI, 1 mM MgS04,
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50 mM P-mercaptoethanol, pH 7.0). Thirty microliters of 0.1 % SOS and 50 µI
chloroform were added to each tube and the mixtures were vortexed for
15 seconds and equilibrated for 15 minutes in a 30°C incubator. Then 0.2 ml of
4 mg/ml ONPG was added, the mixtures vortexed 5 seconds, and the tubes
innoculated at room temperature. When a medium-yellow color had developed,
the reaction was stoped by adding 0.5 ml of 1 M sodium carbonate. The
reaction time was noted. The cells were transferred to the eppendorf tubes and
microcentrifuged at 14,000g for 1 minutes. OD420 and 00550 of the
supernatant was determined. The units of p-galactosidase were then
calculated with the following equation:

U= 1000 x[(OD420)-(1.75 xODsso)]
(t) X (v) X (ODeoo)
t = time of reaction (min)
v = volume of culture used in assay (ml)
00600 = cell density at the start of the assay
00 42 0 =combination of absorbance by ONPG and light scattering by
cell debris
00550 = light scattering by cell debris.

5. Yeast p-galactosidase Colony Filter Assay

Please refer to section 3.E.3.
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6. Yeast Genomic DNA Isolation

Yeast genomic DNA was prepared according to the methods of Treco
(1993). A single yeast colony was inoculated into 10 ml YPD medium in a
50-ml sterile, disposable polypropylene tube. The culture was grown
16 to 24 hours at 30°C in a shaking incubator (250 rpm). The tube was
centrifuged

1O minutes at 3000g in a swing-bucket tabletop centrifuge at

4°C. The pellet was resuspended in 0.5 ml of sorbitol solution (0.9 M sorbitol,
0.1 M Tris.HCI pH 8.0, and 0.1 M EDTA). Ten microliters of 1.5 mg/ml
zymolyase in sorbitol solution and 50 µI of 0.28 M

~-mercaptoethanol

were

added to the tube to prepare yeast spheroplasts. The tube was vortexed gently
and then incubated 1 hour at 37°C in a shaking incubator (250 rpm). The cells
were centrifuged (as above). The pellet of spheroplasts was resuspended in
0.5 ml Tris/EDTA solution (50 mM Tris.HCI pH 8.0 and 20 mM EDTA) by
pipetting up and down repeatedly. The suspension was transfered to a 1.5 ml
microcentrifuge tube. Fifty microliters of 10% SOS was added and the tube was
inverted several times to mix. The tube was incubated 20 minutes at 65°C. Two
hundred microliters of 5M potassium acetate was added and the tube was
inverted several times to mix. The tube was set on ice for at least 30 minutes
and microcentrifuged 10 minutes at room temperature or 4°C. The supernatant
was poored into a clean, labeled 1.5 ml microcentrifuge tube and approximate
1 ml 100% ethanol was added. The tube was inverted repeatedly to mix and
microcentrifuged 10 minutes at 4°C. The pellet was resuspended in 300 µI TE
buffer (10 mM Tris.HCI and 1 mM EDTA). resuspension of DNA pellet can be
hastened by incubating the tube at 65°C and periodically finger-flicking or
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vortexing it very gently. Five microliters of 10 mg/ml RNase A was added and
the tube was incubated 1 hour at 37°C. Half a milliliter of 100% isopropanol
was added and the contents were mixed until the DNA precipitated. The tube
was microcentrifuged for 10 minutes. The DNA pellet was resuspended in
50 µI TE.

7. Southern Hybridization of Yeast DNA

Southern hybridization of yeast DNA was performed according to the
methods of Treco (1993). Five micrograms of yeast genomic DNA was digested
with BamHI, C/al, and Hino111 respectively. The digested DNA was
electrophoresed in an 1% (w/v) agarose gel. The gel was soaked in 400 mM
NaOH for 30 minutes at room temperature with gentle shaking to denature the
DNA. The gel was placed on top of two layers Whatman papers and one layer
of zetaprobe filter. The DNA was transferred from the gel to the zetaprobe filter
using a BioRad vacume blotter. The filter was rinsed with 2 x SSC solution
(0.3 M NaCl, 0.03 M Tris-Sodium Citrate) and air dried. The filter was placed in
a hybridization tube. 1O ml of Rapid Hybridization Buffer ( purchased from
Amersham Life Science Inc., Arlington Heights, IL) was added and the tube was
incubated 2 hours at 65°C. A ramdom primed labeled, denatured probe
(prepared by using a random-prime label kit purchased from Amersham Life
Science Inc., Arlington Heights, IL) was added to the tube and the mixture was
incubated 2 hours at 65°C. The hybridization buffer was then removed from the
hybridization tube and 2 x SSC, 0.1 % SDS was added to the filter. The filter
was washed 20 minutes at room temperature. The filter was again washed
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twice in 1 x SSC, 0.1 % SOS 20 minutes at room temperature. The filter was
exposed to Kodak film with an intensifying screen at -70°C for 16 hours.

8. Northern Blot Analyses

Yeast total RNA was isolated as described in Chapter 2. Formaldehyde
gel electrophoresis separated RNA for Northern blot analysis according to the
method of Clouet d'Orval et al., (1986). Fifteen micrograms of total RNA were
heated to 95°C for 2 min to denature the RNA. RNA samples were
electrophoresed in a formaldehyde/agarose gel. The gel was rinsed for
20 minutes each in two changes of 500 ml of 1O x SSC to remove formaldehyde
from gel. A 20 x 30 cm glass plate was placed over a tray filled with 500 ml of
1O x SSC. A piece of Whatman 3MM filter was wet with 1O x SSC buffer and
draped over the glass plate, with both ends hanging into the buffer (to act as
wick). The gel was placed carefully upside down (i.e. sample well opening
down) over wick. A Zetaprobe nitrocellulose (NC) filter was wet with H2o and
placed on top of gel. All air bubbles were smoothed out. Two pieces of
Whatman 3MM paper was wet with H20 and laid individually on top of the NC
filter and smoothed. Layers of folded paper towels were stacked flat over 3MM
paper and were covered with a 20 x 30 cm glass plate. A small weight was
placed on top. The transfer of RNA from gel to NC filter by capillary action
proceeded for at least 12 hours at room temperature. After transfer, paper towel
stacks and paper sheets were removed. The filter was rinsed once with
2 x SSC and subsequently air dried at room temperature for 30 minutes. The
filter was then UV- crosslinked for 12 seconds before hybridization. The filter
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was hybridized with a random-prime 32p labeled DNA probe (prepared by
using a random-prime label kit obtained from Amersham Life Science Inc.,
Arlington Heights, IL) in the presence of rapid hybridization buffer (Amersham
Life Science Inc., Arlington Heights, IL). The hybridization was at 42°C. The
filter was subsequently washed in 2 x SSC at room temperature and
autoradiographed.

9. Determination of mRNA Decay Rates

For determination of mRNA decay rates, cultures of cells were incubated
with 100 ug/ml of 1, 10-phenanthroline (Santiago et al., 1986) during
exponential growth. Immediately after addition of the drug, cells were shifted to
the restrictive temperature for various lengths of time. Following various amount
of time at the restrictive temperature, cells were harvested rapidly by a brief
centrifugation (20 seconds at 1O,OOOg) and cell pellets were frozen in dry ice.
Total RNA was then isolated as described in section 3.E.4.

CHAPTER 3

IDENTIFICATION AND CHARACTERIZATION OF YEAST MUTANTS
THAT OVERCOME AN EXPERIMENTALLY INTRODUCED BLOCK TO
SPLICING AT THE 3' SPLICE SITE
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A. Abstract

An experimentally introduced secondary structure in exon 2 adjacent to
the 3' splice site of a yeast ACT-E coli /acZfusion gene abolishes splicing in
vivo and inhibits B-galactosidase production. We have devised a genetic screen
to isolate both cis and trans-acting mutants which restore B-galactosidase
activity. Two cis-acting mutants potentially destabilize the stem in the region
close to the 3' splice site. One trans-acting mutant designated rss1-1 partially
restores B-galactosidase activity by b9th increasing the splicing efficiency and
stabilizing the precursor and lariat intermediate. The trans-acting suppression
activity of rss 1-1 is specific for a particular structure since another artificially
introduced secondary structure, which also blocks splicing, is not suppressed
by this mutant allele. We have cloned the gene encoding the trans-acting
mutant protein. The RSS1 gene is located on Saccharomyces cerevisiae
chromosome Vandis a single copy, essential gene. The predicted RSS1
protein has marked similarity to members of the putative ATP-dependent RNA
helicase family. At the nonpermissive temperature the rss1-1 mutant allele
decreases the steady-state levels of several endogenous messenger RNAs and
increases the ratio of pre-mRNA to mRNA of specific messages. RSS1 is likely
to play an interesting role in RNA processing.

B. Introduction

Pre-mRNA splicing is a fundamental process in eukaryotic cells and can
be regulated in a number of ways. One factor that has been invoked in splicing
regulation is RNA secondary structure. In recent years, it has been
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demonstrated that RNA secondary structure can affect splice site selection and
splicing efficiency. We have previously reported that a naturally occurring
pre-mRNA secondary structure sequesters the proximal 3' splice site of the
budding yeast Kluyveromyces lactis actin intron and is required for activation of
the distal 3' splice site (Deshler & Rossi, 1991 ). Eng and Warner showed that
regulation of the splicing of the ribosomal protein RPL32 pre-mRNA in

Saccharomyces cerevisiae, may depend on the formation of a stem-loop
structure which includes the 5' splice site (Eng & Warner .. 1991 ). Experimentally
introduced hairpins which sequester 5' splice site or branch point regions
strongly inhibit splicing in yeast, both in vivo and in vitro (Yoshimatsu &
Nagawa, 1989; Goguel et al., 1993). Inhibitory effect of hairpins with potential to
sequester the 5' splice site have also been observed in the dicot plant Nicotiana

plumbaginifolia (Goodall & Filipowicz, 1991; Liu et al., 1995). In mammalian
systems, secondary structure can strongly influence the selection of alternative
splice sites, regulating formation of multiple mRNAs from the same transcript
(Clouet d'Orval et al., 1991; Libri et al., 1991; Solnick 1985; Watakabe et al.,
1989).
We have observed that an artificially introduced stem-loop structure,
formed by a mutant hammerhead ribozyme inserted 5 nucleotides downstream
of the ACT 3' splice site in a yeast ACT-E. coli lacZ fusion gene, virtually
abolishes splicing in vivo and inhibits expression of lacZ (Castanotto et al., in
prep). To understand how splice site context, especially proximity to a
secondary structure, can affect utilization of splice sites, we screened for
cis- and trans-acting suppressor mutations that restored splicing, thereby
allowing functional expression of the ACT-mrz-lacZ fusion message. We
isolated four mutants, two cis-acting and two trans-acting, which partially
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restored expression of the ACT-mrz-lacZ fusion gene. We have cloned the
gene encoding the trans-acting mutant protein, designated RSS1 (RNA Stability
and Splicing). RSS1 is located on S. cerevisiae chromosome V. The predicted

RSS1 gene product has marked similarity to members of the DExH family of
ATP-dependent RNA helicases. We report evidence here that RSS 1 is a novel
protein involved in mRNA splicing and stability. Activation of the 3' splice site
the cis-acting mutants is most probably a consequence of destabilization of a
stem structure adjacent to the 3' splice signal. The rss1 mutant encodes a
protein which recognizes the secondary structure in such a manner as to
stabilize both the precursor and lariat intermediates. We speculate that this
stabilization interaction is accompanied by a local unwinding of the stem,
thereby allowing step 2 of the splicing reaction to take place.

C. Results

1. A Stem-Loop Structure Close to the 3 Splice Site
1

Inhibits Both Steps of Yeast Pre-mRNA Splicing,
Predominantly the Second Step

A yeast ACT-E. coli lacZ fusion gene was constructed in which the
promoter, exon 1 and intron sequences of the yeast ACT gene were fused to the

E. coli lacZ gene. B-galactosidase expression is dependent on splicing of the
yeast ACT intron (Deshler & Rossi, 1991 ). We have observed that a cis-acting
mutant hammerhead ribozyme, inserted 5 nucleotides downstream of the ACT
3' splice site in exon 2 of the yeast ACT-E. coli lacZ fusion gene, virtually
abolishes splicing in vivo and inhibits B-galactosidase expression. Even
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reverse transcriptase initiated PCR (RT-PCR) analysis did not reveal spliced
transcripts. This inhibition is observed regardless of whether the ribozyme is
active or inactive (mutant ribozyme), or inserted in a sense or antisense
orientation (Castanotto et al., in prep). Approximately 0.02 units of
B-galactosidase were produced from pJYH7-mrz, compared to 350
B-galactosidase units from the parental vector pJYH7 (Fig. 9A). Yeast colonies
harboring the vector pJYH7-mrz are white upon X-gal colony filter assay,
whereas yeast colonies harboring pJYH7 are blue (Fig. 9A).
To determine which step of the splicing reaction the stem-loop structure
impedes, we carried out primer extension analyses of RNAs using a primer (ivs)
that hybridizes to the intron region upstream of the branch point (Fig. 98). If
annealed and extended, the ivs primer will generate a 170-nt cDNA product
corresponding to the pre-mRNA, as well as a 68-nt product corresponding to the
lariat intermediate or excised intron-lariat. As shown in Fig. 98, primer extension
of RNA extracted from JM43 cells transformed with pJYH7 showned no
detectable products corresponding to pre-mRNA or lariat intermediate,
suggesting efficient splicing of the yeast ACT-E. coli /acZ fusion gene. In
contrast, primer extension analyses of RNA extracted from JM43 cells
transformed with pJYH7-mrz resulted in a marked accumulation of pre-mRNA
and lariat intermediate (Fig. 98). Although the ivs primer could not differentiate
between lariat intermediate and excised intron-lariat, we believe the observed
68-nt cDNA product is derived solely from lariat intermediate since excised
intron-lariat was not even detectable from pJYH7 carrying the efficiently spliced
ACT intron. These data demonstrate that the stem-loop structure close to the
3' splice site represses the utilization of both step 1 and 2 of splicing, but
primarily step 2.
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Figure 9. A: Schematic representation of the S. cerevisiae ACT-E. coli lacZ
fusion gene in plasmid pJYH7 and the ACT-mrz-/acZ fusion gene in plasmid
pJYH7-mrz. A mutant ribozyme (see Fig. 28 for sequence and secondary
structure) was cloned 5 nucleotides downstream of ACT 3' splice site and in
the lacZ reading frame. B-Galactosidase activities derived from these are
indicated (a: units of B-galactosidase activity in this paper were determined as
an average value of three independent measurements unless otherwise
stated.)
B: Primer extension analyses of total RNA prepared from S. cerevisiae JM43
cells transformed with pJYH7 or pJYH7-mrz. The ivs primer complementary to
the intron region upstream of the branch point of the ACT-mrz-/ac Z fusion
transcripts is indicated by a black dot. The primer extension products are·
shown schematically beside the autoradiograph by wavy lines. The products
corresponding to pre-mRNA and lariat intermediate were normalized to U6
snRNA to ensure that equivalent amounts of total RNA were used for primer
extension reactions. Quantitation was carried out using a Bio-Rad Phosphor
Analyst/PC.
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2. A Genetic Screen Scheme for Identification of Cis- and
Trans-Acting Suppressors Which Restore B-Galactosidase
Expression

In order to better understand how splice site context, especially proximity
to a secondary structure can affect splice site utilization, we devised a genetic
screen to isolate both intragenic (cis) and extragenic (trans) suppressors of
pJYH7-mrz that could restore B-galactosidase expression (Fig. 10).
S. cerevisiae JM43 strain cells harboring pJYH7-mrz were chemically
mutagenized with ethyl methanesulfonate (EMS) and plated on CSM (minus
uracil) medium at 23 °C to select for transformants. To identify mutants, B-gal
yeast colony filter assays were performed. Colonies that expressed
B-galactosidase (blue upon X-Gal staining) were identified and purified. To
determine whether restoration of B-galactosidase expression was due to a
plasmid borne or chromosomal mutation, plasmid DNAs were cured from yeast
cells by growing them under nonselective conditions. Unmutagenized
pJYH7-mrz plasmid DNAs were then transformed into the cured cells and B-gal
yeast colony filter assays were performed. Colonies with restored B-gal
expression harbored trans-acting suppressors; colonies that were B-gal
negative had previously contained cis-acting, plasm id borne suppressors.
Using this strategy, we have isolated two cis- and two trans-acting suppressors.
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S. cerevisiae transformants harboring pJYH7-mrz

I mutagenized with EMS l

•
•
•

I plated on CSM (-1Jracil) plates I
perform p-gal yeast colony filter assay

0
0

I

0
0
0

0
0

identify blue colonies, cure plasmid DNAs,
tsf w/ unmutagenized pJYH7-mrz plasmid DNA,
perform P-gal yeast colony filter assay

White
cis-acting mutant(s)

Still Blue ·
trans-acting mutant(s)

Figure 10. Strategy to isolate cis - and trans-acting mutants that
alleviate the splicing blockage exerted by the hammerhead ribozyme
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3. Cis-Acting Suppressors Potentially Destabilize the Stem of
the Mutant Ribozyme in Proximity to the 3' Splice Site

The two cis-acting suppressors isolated allow partial restoration of
B-galactosidase expression. About 1.3 and 4 units of B-galactosidase activities
were observed in cis-mutant 31 and 38 respectively (Fig. 11A). Sequencing of
the entire ACT intron and adjacent exon sequences including the mutant
ribozyme revealed that the mutants had single base alterations in the ten base
pair stem Ill of the mutant ribozyme construct (Fig. 118). Mutant 31 had a single
G to A transition and mutant 38 a G to T transversion. Both mutations potentially
destabilize base pairing in the stem, suggesting that the stem close to the splice
site played a pivotal role in inhibition of splicing and that local breathing of the
stem could lead to reutilization of the splice site.

4. The Trans-Acting Suppressor is Temperature Sensitive

Out of -100,000 EMS mutagenized pJYH7-mrz transformed yeast cells
sc.reened, two independent trans-acting suppressors were recovered. About
13 units of B-galactosidase activity were produced from the pJYH7-mrz in both
trans-mutants compared to 0.02 units of B-galactosidase activity in the parental
JM43 strain. In addition to partial restoration of B-galactosidase expression, we
also observed a temperature sensitive phenotype in both mutants. Tetrad
analyses of one of the mutant isolates, JL2, showed that the temperature
sensitive phenotype segregated 2:2 in more than 30 tetrads tested, suggesting
a mutation at a single genetic locus. To determine whether the temperature
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A
p-gal activity

Yeast Colony Filter Assay

Cis-mutant 38

4 units

Blue

Cis-mutant 31

1.3 units

Blue

B
u c
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CAGCUGtCtGCCGAGUA GU CAGCCUGGGC

U A
(38) (31)

Figure 11. A: B-Galactosidase activities of the two cis-acting mutants are
indicated. B: Mutations recovered in cis-acting mutants that were
responsible for partial restoration of B-galactosidase expression. Shown is
another schematic representation of the ACT-mrz-lacZ fusion gene. The
mutant hammerhead, cis-targeted ribozyme was inserted into a Sal I site
(GTCGAC) 5 nucleotides downstream of ACT 3' splice site and has a
potential to form stable stem-loop secondary structure in vivo. In the cisacting mutant 31, a single mutation was identified in stem Ill of the mutant
ribozyme close to the 3' splice site, replacing a G with an A. In the cisacting mutant 38, another single mutation in the same stem replaced a G
with a T.
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sensitive phenotype and the ability to restore B-galactosidase activity were
genetically linked, we transformed pJYH7-mrz into independently isolated
colonies derived from 4 temperature sensitive spores and 4 temperature
resistant spores and performed a yeast colony filter assay. All the temperature
sensitive colonies became blue and the temperature resistant colonies
remained white upon X-Gal staining. This suggests that the temperature
sensitive phenotype and the suppressor phenotype cosegregated and were
due to a single mutation. The temperature sensitive phenotype of JL2 was
found to be recessive as judged by the growth at 37

°c of diploids formed by

mating JL2 to a wild type strain. The suppressor phenotype was found to be
dominant as judged by the increased B-galactosidase from ACT-mrz-lacZ in the
heterozygous diploid. Complementation analyses showed that JL2 fell into a
single complementation group with the other mutant isolate. JL2 was used for
further characterization of the trans-acting mutations.

5. The Trans-Acting Suppressor Restores B-Galactosidase
Expression from ACT-mrz-/acZ by Both Increasing Pre-mRNA
Stability and Enhancing Splicing Efficiency at the Permissive
Temperature

To understand how the JL2 mutant strain restored B-galactosidase
expression from ACT-mrz-lacZ, primer extention analyses of RNAs extracted
from the JL2 mutant and the wild type JM43 cells transformed with pJYH7-mrz
were carried out {shown in Fig. 12). The ivs primer complementary to the intron
region upstream of the branch point was used. The extended cDNA products
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Figure 12. Primer extension analyses of RNAs. Total RNAs extracted from the
wild type JM43 and the trans-acting mutant JL2 cells transformed with the
pJYH7-mrz were subject to primer extension analyses using the ivs primer. The
extended products were electrophoresed in a denaturing 6% polyacrylamide
gel. Shown is an autoradiograph after a 24 hour exposure. The position of the
ivs primer hybridization is indicated by a black dot. The primer extension.
products are shown schematically beside the autoradiograph by wavy lines.
The products corresponding to pre-mRNA and lariat intermediate were
normalized to U6 snRNA. Quantitation was carried out using a Bio-Rad
Phosphor Analyst/PC.
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were quantitated and normalized to U6 snRNA. Relative to JM43, the JL2
mutant allele increased the level of the ACT-mrz-/acZpre-mRNA 2-fold and the
level of lariat intermediates 4-fold at the permissive temperature. The increased
levels of pre-mRNA and lariat intermediate could be due to, a) up-regulated
transcription, b) inhibition of splicing and/or c) increased RNA stability. Since
the plamid-borne ACT-mrz-lacZ fusion gene utilized the same promoter as
endogenous ACT1, we examined the effect of the mutant allele on the
endogenous ACT1 transcript levels at the permissive temperature. Primer
extension analyses using the ivs. primer to detect endogenous ACT1
pre-mRNAs showed that the mutant allele had no discernible effect on
endogenous ACT1 pre-mRNA levels at 23 °C (Fig. 13). Based upon these data,
it is unlikely that the mutant allele up-regulates transcription. Inhibition of
splicing alone cannot account for the higher amounts of pre-mRNA in the
mutant background since that would decrease the mature B-galactosidase
transcript levels and downregulate B-galactosidase expression. We therefore
reason that the mutant JL2 increased the steady-state levels of ACT-mrz-lacZ
pre-mRNA and lariat intermediate.
To demonstrate mature ACT-mrz-lacZ mRNA levels, We performed
quantitative RT-PCR analyses (Fig. 14). Reverse transcription and thirty cycles
of PCR amplication of RNAs extracted from the JL2 mutant transformed with
pJYH7-mrz gave rise to a DNA product corresponding to the spliced
ACT-mrz-lacZ mRNA while the wild type JM43 did not. The amplified DNA

product was purified form the gel, eluted, reamplified, sequenced and verified to
be the spliced ACT-mrz-lacZ transcript. RT-PCR analyses of the ACT1 spliced
product were carried out as an internal spliced RNA standard (Fig. 14).
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Figure 13. Primer extension analyses of RNAs. Total RNA extracted from the
wild type JM43 and the mutant JL2 cells (grown at 23 °C) were subject to primer
extension analysis using the ivs primer. Since wild type ACT1 is efficiently
spliced, we did not detect any ACT1 pre-mRNA in an autoradiograph after a 24
hour exposure (data not shown). Shown here is an autoradiograph following an
extented (one week) exposure.
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11111

ACT1 spliced

11111

ACT-mrz-/acZ spliced

Figure 14. RT-PCR analyses of mature ACT-mrz-/acZmRNA levels in the wild
type JM43 versus the mutant JL2 cells. RNAs were extracted from the wild type
JM43 and the trans-acting mutant JL2 cells transformed with the pJYH7-mrz.
RT-PCR analyses were carried out as described in Materials and Methods.
Endogenous ACT1 mRNA was used as an internal standard for relative
quantitation of the ACT-mrz-lacZ mRNA RT-PCR products.
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Taken together, the results of RNA analyses showed that the mutant JL2
restored B-galactosidase expression from ACT-mrz-/acZ by both increasing
pre-mRNA stability and enhancing splicing efficiency.
We have compared the fold increase in B-galactosidase activity
expressed from ACT-mrz-lacZ and ACT-L\IVS in the mutant cells. ACT- .!\IVS
was constructed by a precise deletion of the intron in ACT-mrz-/acZ. As shown
in Table 1, the mutant gave rise to 650-fold increase in B-galactosidase activity
expressed from ACT-mrz-lacZ compared to only approximately 2-fold increase
in B-galactosidase activity from ACT- .!\IVS. These data clearly indicate that the
mutant acts in an intron-dependent fashion.

6. The Trans-Acting Suppressor Activity is Specific for the
Mutant Ribozyme Secondary Structure

To address whether the trans-acting suppressor activity was specific for
primary sequences or secondary structure of the mutant ribozyme, we replaced
the mutant ribozyme with the antisense sequences of the ribozyme which also
blocks 3' splice site utilization in JM43. With this construct, the trans-acting
suppressor restored B-galactosidase production to a level similar to
ACT-mrz-lacZ, suggesting that the suppressor recognizes secondary structure
as opposed to a primary sequence. We have also tested the cis-acting mutants
which have a secondary structure similar as the mutant ribozyme (Fig. 11 B)
and found that the splicing of these transcripts was substantially increased
(15 fold) in the context of the trans-acting suppressor (Table 2).
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Table 1. Fold increase in ~-galactosidase activity between mutant
and wild-type cells.

Construct
ACT-m rz- lacZ
ACT-AIVS

Fold increase in
~-gal activity

.......

650

2

The mutant and wild type cells have been transformed with
plasmids containing ACT-mrz-/acZ and ACT-AIVS (intron-less
construct of ACT-mrz-/acZ) respectively. The ACT-mrz-/acZ
construct displayed a 650 fold increase in ~-galactosidase activity
when expressed in the mutant cells compared to wild type cells
(13 units vs. 0.02 units respectively). The ACT-AIVS construct
displayed approximately 2 fold increase in ~-galactosidase activity
when expressed in the mutant cells compared to wild type-cells
(122 ± 4 units vs. 51 ±1 units respectively).
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Table 2. P-Galactosidase activity derived from the cis-mutant 31
in the wild-type JM43 and the muant JL2 cells.

Cells

~gal

Wild-type

1.3±0.3 units

Mutant

20±1.8 units

activity
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We next tested a secondary structure different from that of the mutant
ribozyme. An 8-nucleotide hairpin was introduced into the yeast ACT-E. coli

lacZ gene at the same site where the mutant ribozyme has been inserted,
creating the ACT-SL-/acZ fusion gene (Fig. 15A). The plasmid pJYH7-SL
containing the ACT-SL-/acZ fusion gene expressed 2-fold lower levels of
13-galactosidase activity than pJYH7 in JM43, suggesting an inhibitory effect of
the a-nucleotide hairpin on splicing. When pJYH7-SL was transformed into the
mutant JL2 background, 13-galactosidase activity was even suppressed further
(Fig. 158). This is in contrast with the 13-galactosidase activity restoration effect
of the JL2 strain on pJYH7-mrz. Total RNA prepared from pJYH7-SL
transformed JL2 and JM43 cells was prepared and used for primer extension
analyses with the ivs primer (Fig. 15C). After quantitation and normalization to
U6 snRNA, it was found that the mutant JL2 strain accumulated the
ACT-SL-/acZ lariat intermediate by a factor of -2-fold over that observed in
JM43. Concomitant with the increase in lariat intermediate, a decreased mature
ACT-SL-/acZ mRNA level was observed in the mutant JL2 background by
RT-PCR analyses (Fig. 150). These data showed that the trans-acting
suppressor had the effect of inhibiting splicing to the ACT 3' splice site when the
a-nucleotide stem-loop in exon 2 was present. This opposite effect of the
trans-acting suppressor on 13-galactosidase expression from pJYH7-SL and
pJYH7-mrz suggests that the mutant allele, herein refered to as rss1-1 (standing
for RNA ~tability and

~plicing),

the a-nucleotide hairpin.

interacts differently with the mutant ribozyme and

62

Figure 15. A: Schematic representation of the ACT-SL-/acZ fusion gene. An
a-nucleotide stem-loop was introduced into the yeast ACT-£. coli JacZ gene at
the same site where the mutant ribozyme was inserted. B: B-Galactosidase
activities derived from the plasmid pJYH7-SL containing the ACT-SL-/acZ
fusion gene in the parental JM43 and the mutant JL2 cells. Values are given
as means± SEM. n = 13 for both JM43 and JL2 cells. C: Total RNAs
prepared from the parental JM43 and the mutant JL2 cells transformed with
pJYH7-SL were subject to primer extension analyses using the ivs primer.
D: Quantitave RT-PCR analyses of decreaced splicing efficiency of the
ACT-SL-/acZ gene in the mutant JL2 cells as compared to the wild type
JM43 cells. Quantitave RT-PCR analyses were carried out as described in
Materials and Methods. Endogenous ACT1 mRNA was used as an internal
standard for relative quantitation of the ACT-SL-/acZ pre and mature mRNA
RT-PCR products.
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AGAGCGCCGGCGU
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7. rss 1-1

Decreases the Steady-State Levels of Wild Type

Messages at the Restrictive Temperature and Accumulates
Pre-mRNA of Specific Message(s) in vivo

As described above, rss1-1 increases the stability of the ACT-mrz-lacZ
fusion transcripts. It was thus reasonable to ask the question: Does rss1-1 affect
the stability of wild type messages? To test this, we analyzed the steady-state
levels of three wild type transcripts in the rss1-1 mutant strain. As shown by
primer extension analyses (Fig. 16A), rss 1-1 did not alter the steady-state level
of mature actin mRNA at the permissive temperature (23 °C). However, after a
shift to 36 °C for 1 hour, the mutant allele resulted in a significant decrease of
mature actin transcripts, compared with no detectable change in actin mRNA
levels in JM43 at 36 °C. Northern blot analyses also demonstrated a reduction
in mature mRNA levels of RP51A and CYH2 transcripts (Fig. 168 and 16C). No
accumulation of ACT1 and CYH2 pre-mRNAs and lariat intermediates was
detected. However, Northern blot analyses of RP51A transcripts indicated slight
accumulation of ribosomal protein 51A pre-mRNA transcripts at both the
permissive and nonpermissive temperatures, although far less than in the
prp2-1 mutant (Fig. 168). No accumulation of ACT1 or CYH2 pre-mRNAs were
observed (Fig. 168 & 16C).

8. Cloning of the R 551 Gene

The wild type RSS1 gene was cloned by complementation of the
temperature sensitive phenotype of the rss1-1 mutant allele. A YCp50-yeast

66

Figure 16. A: Primer extension analyses of actin mRNA using a 32p endlabeled pet23 primer that hybridized to exon 2 of the actin gene. Total RNA
was extracted from the wild type and the rss1 mutant cells grown at 23 QC and
after a 2 hour shift to 36 QC. The cDNA products were normalized to U6
snRNA. B: Northern blot analyses of RP51A mRNA. Total RNA was extracted
from the prp2-1, the wild type JM43, the rss1-1 mutant cells grown at 23 QC
and after a 1 hour shift to 36 QC. 15 µg of the total RNAs were loaded on a
1% formaldehyde agarose gel. Following electrophoresis and blotting, the
RNAs were hybridized to 32p end-labeled oligonucleotide probes
complementary to RP51A. C: Northern blot analyses of CYH2 mRNA. Total
RNA was extracted from the wild type JM43 and the rss1-1 mutant cells grown
at 23 QC and after a 1 hour shift to 36 QC. 15 µg of the total RNAs were loaded
on a 1% formaldehyde agarose gel. Following electrophoresis and blotting,
the RNAs were hybridized to a 32p end-labeled oligonucleotide probe
complementary to CYH2.
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genomic DNA library was transformed into the rss1-1 temperature sensitive

S. cerevisiae JL2 strain. Of -67,000 transformants screened, five
complementing colonies were isolated. Plasmid DNAs from these cells were
isolated and reintroduced into JL2. In all cases, plasmid DNAs conferred
temperature resistance at 37 °C. The five plasmid DNAs contained the same
11 kb yeast genomic insert defined by restriction enzyme digestion patterns.
Subcloning narrowed the complementation activity to a 7. 7kb Sac l-Sau3A
fragment (Fig. 17).
Genetic evidence that the complementing clone harbored the wild type

RSS 1 allele rather than an extragenic suppressor was provided by targeted
integration of the cloned sequence into the chromosomal region genetically
linked to the original rss1-1 mutation (Fig. 18). A Sac I-Hind Ill fragment which
contained the 5' end of the RSS1 ORF was subcloned into an integrating vector
pRS305 (Sikorski & Hieter, 1989). The resulting plasmid pRS305-3ASH,
contained both the LEU2 gene and the 5' end of the RSS1 ORF. This vector
was linearized at a unique Bam HI site and transformed into a leu2, rss 1-1
strain resulting in LEU+, temperature sensitive transformants. One of the stable
LEU+, temperature sensitive transformants was then crossed with a leu2 RSS1
strain. The resulting diploid was sporulated and 30 tetrads were analyzed.
Cosegregation of the temperature sensitivity and LEU2 and of temperature
resistance and leu2 in each tetrad was observed, verifying that the integration
had occured at the RSS1 locus, and that the cloned gene was indeed RSS1.
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Figure 17. Complementation analyses. The horizontal bars represent
DNA fragments that were tested for their ability to complement the
rss1-1 temperature sensitive defect. pLIN3A was the original RSS1
isolate consisting of an 11-kb Sau 3A-Sau 3A insert cloned into the
YCpSO Barn HI site. pLIN3A 1 consists of a 4.4-kb Cla I-Sau 3A fragment
cloned into YCpSO. pLIN3A2 consists of a 6.2-kb Sac I-Sal I fragment
cloned into pSEYC68. pLIN3A3 consists of a 7.8-kb Sau 3A-Sac I
fragment cloned into YCpSO.
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FIGURE 18. Genetic evidence that the complementing clone harbored the
wild-type RSS1 allele rather than an extragenic suppressor. A. The
integrating plasmid, PRS305-3ASH, containing LEU2 and 5' end of RSS1,
was linearized at a .unique 8amH1 site and transformed into a leu2, rss1-1,
strain. B. The resulting strain is Leu+ and ts-. C. This strain was then crossed
with a leu2 RSS1 strain. The resulting diploid was sporulated and 30 tetrads
were analyzed. Cosegregation of the temperature sensitivity (ts-) and LEU2
and of temperature resistance (Ts+) and leu2 in each tetrad was observed.
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9. RSS1 is a Single Copy Gene and is Essential for Yeast
Cell Viability

Southern hybridization of JM43 genomic DNA cut with several different
restriction endonucleases and probed with a randomly primed labeled
3.3kb Hind Ill-Sac I fragment gave only single bands of hybridization (data not
shown). These data suggested that RSS1 is a single copy gene.
In order to determine if RSS1 was essential for viability, we replaced one
copy of the wild type RSS1 gene with a deletion-frameshift allele rss1::LEU2, in
the diploid yeast strain JL4. As shown in Fig. 19, linearized pRS305-3AH3,
containing the deletion-frameshift allelle and the LEU2 marker, was transformed
into JL4, a diploid strain homozygous for the wild type RSS1 allele and for leu2.
The resulting Leu+ transformants, presumably of the genotype RSS1rss1::Leu2,
were sporulated and dissected. Only one or two spores were recovered from
each tetrad. All of the viable spores were Leu· auxotrophs, indicating that the
deletion-frameshift allele of RSS1 is lethal. This lethality of the rss1:: LEU2 null
allele could be complemented by a plasmid borne, wild type allele of RSS1
prior to sporulation(data not shown). These results demonstrated that the RSS1
gene is essential.

10. RSS1 Encodes a Putative ATP-Dependent RNA
Helicase

Comparison of a partial nucleotide sequence of RSS1 with GeneBank
demonstrated that this sequence derives from S. cerevisiae chromosome V, the
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Figure 19. RSS1 is essential for yeast cell viability. The integrating plasmid,
PRS305-3AH3, containing the deletion-frameshift allele and the LEU2 marker,
was linearized with BamH 1 and transformed into a diploid strain homozygous
for the wild type RSS1 allele and leu2. The resulting Leu+ transformants were
sporulated and dissected. Only one or two spores were recovered from each
tetrad. None of the viable spores were Leu+.
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entirety of which has been sequenced (Dietrich FS et al., unpublished data). A
7.7kb Sau3A-Sac I fragment (Fig. 17), the smallest which complemented
temperature sensitivity, contained a single ORF of 6,492-nucleotides. No
consensus intron sequences were found, suggesting that the 6,492-nucleotide
ORF is uninterrupted and could encode a protein of 2, 164 amino acids. The
deduced amino acid sequence of RSS1 was compared with other known
protein sequences in the non-redundant data base avai'lable at NCBI through
the BLAST network server (Altschul et al., 1990). RSS1 is identical to a yeast
hypothetical 264.2 KO protein and has a central domain of approximately
357 amino acids that is similar to the superfamily of ATP-dependent DNA/RNA
helicases (Fig. 20). The sequence of amino acids 521 to 528 contains an A
motif characteristic of ATPases (Walker et al., 1982) which has been shown to
be involved in ATP binding (Rozen et al., 1989). The DEIH sequence between
amino acids 634-637 is a B motif of ATPases and is also thought to be required
for ATP binding (Walker et al., 1982). The motifs SAT and GRAGR (positions
671-673 and 873-877) are also conserved among the superfamily of
ATP-dependent DNA/RNA helicases (Gorbalenya et al., 1988 & Gorbalenya et
al., 1989). The function of these sequences is unknown, although it is
postulated that they may be important for nucleic acid binding and helicase
activity of these proteins (Gorbalenya et al., 1989; Linder et al., 1989; Pause et
al, 1993). Not only does RSS1 possess conserved helicase motifs, these motifs
are also at conserved positions (Gorbalenya et al., 1989). The 357-residue
central domain, which is similar with ATP-dependent DNA/RNA helicases, is
flanked by 520 amino-terminal residues and 1286 carboxyl-terminal residues of
unique sequence. A second ATP-binding domain was found in the
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MTEHETKDKAKKI RE I YRYDEMSNKVLKVDKRFMNTSQNPQRDAE ISQPKSMSGRISAKD
MGQGLCNNINKGLKENDVAVEKTGKSASLKKIQQHNTILNSSSDFRLHYYPKDPSNVETY
EQILQWVTEVLGNDIPHDLIIGTADIFIRQLKENEENEDGNIEERKEKIQHELGINIDSL
KFNELVKLMKNITDYETHPDNSNKQAVAILADDEKSDEEEVTEMSNNANVLGGEINDNED
DDEEYDYNDVEVNSKKKNKRALPNIENDIIKLSDSKTSNIESVPIYSIDEFFLQRKLRSE
LGYKDTSVIQDLSEKILNDIETLEHNPVALEQKLVDLLKFENISLAEFILKNRSTIFWGI
RLAKSTENEIPNLIEKMVAKGLNDLVEQYKFRETTHSKRELDSGDDQPQSSEAKRTKFSN
PAIPPVIDLEKIKFDESSKLMTVTKVSLPEGSFKRVKPQYDEIHIPAPSKPVIDYELKEI
TSLPDWCQEAFPSSETTSLNPIQSKVFHAAFEGDSNMLICAPTGSGKTNIALLTVLKALS

60
120
180
240
300
360
420
480
s40

Belicase I (ATP binding)

HHYNPKTKKLNLSAFKIVYIAPLKALVQEQVREFQRRLAFLGIKVAELTGDSRLSRKQID
ETQVLVSTPEKWDITTRNSNNLAIVELYRLLIIDEIHLLHDDRGPVLESIVARTFWASKY

600
660

Helicase II
GQEYPRIIGLSATL~NYEDVGRFLRVPKEGLFYFDSSFRPCPLSQQFCGIKERNSLKKLK

120

Helicase III

AMNDACYEKVLESINEGNQIIVFVHSRKETSRTATWLKNKFAEENITHKLTKNDAGSKQI

780

Helicase IV

LKTEAANVLDPSLRKLIESGIGTHHAGLTRSDRSLSEDLFADGLLQVLVCTATLAWGVNL

840

Helicase v
~AHTVIIKGTDVYSPEKGSWEQLSPQDVLQMLGRAGRPRYDTFGEGIIITDQSNVQYYLS

900

Belicase VI

VLNQQLPIESQFVSKLVDNLNAEVVAGNIKCRNDAVNWLAYTYLYVRMLASPMLYKVPDI
SSDGQLKKFRESLVHSALCILKEQELVLYDAENDVIEATDLGNIASSFYINHASMDVYNR
ELDEHTTQIDLFRIFSMSEEFKYVSVRYEEKRELKQLLEKAPIPIREDIDDPLAKVNVLL
QSYFSQLKFEGFALNSDIVFIHQNAGRLLRAMFEICLKRGWGHPTRMLLNLCKSATTKMW
PTNCPLRQFKTCPVEVIKRLEASTVPWGDYLQLETPAEVGRAIRSEKYGKQVYDLLKRFP
KMSVTCNAQPITRSVMRFNIEIIADWIWDMNVHGSLEPFLLMLEDTDGDSILYYDVLFIT
PDIVGHEFTLSFTYELKQHNQNNLPPNFFLTLISENWWHSEFEIPVSFNGFKLPKKFPPP
TPLLENISISTSELGNDDFSEVFEFKTFNKIQSQVFESLYNSNDSVFVGSGKGTGKTAMA
ELALLNHWRQNKGRAVYINPSGEKIDFLLSDWNKRFSHLAGGKIINKLGNDPSLNLKLLA
KSHVLLATPVQFELLSRRWRQRKNIQSLELMIYDDAHEISQGVYGAVYETLISRMIFIAT
QLEKKIRFVCLSNCLANARDFGEWAGMTKSNIYNFSPSERIEPLEINIQSFKDVEHISFN
FSMLQMAFEASAAAAGNRNSSSVFLPSRKDCMEVASAFMKFSKAIEWDMLNVEEEQIVPY
IEKLTDGHLRAPLKHGVGILYKGMASNDERIVKRLYEYGAVSVLLISKDCSAFACKTDEV
IILGTNLYDGAEHKYMPYTINELLEMVGLASGNDSMAGKVLILTSHNMKAYYKKFLIEPL
PTESYLQYIIHDTLNNEIANSIIQSKQDCVDWFTYSYFYRRIHVNPSYYGVRDTSPHGIS
VFLSNLVETCLNDLVESSFIEIDDTEAEVTAEVNGGDDEATEIISTLSNGLIASHYGVSF
FTIQSFVSSLSNTSTLKNMLYVLSTAVEFESVPLRKGDRALLVKLSKRLPLRFPEHTSSG
SVSFKVFLLLQAYFSRLELPVDFQNDLKDILEKVVPLINVVVDILSANGYLNATTAMDLA
QMLIQGVWDVDNPLRQIPHFNNKILEKCKEINVETVYDIMALEDEERDEILTLTDSQLAQ
VAAFVNNYPNVELTYSLNNSDSLISGVKQKITIQLTRDVEPENLQVTSEKYPFDKLESWW
LVLGEVSKKELYAIKKVTLNKETQQYELEFDTPTSGKHNLTIWCVCDSYLDADKELSFEI
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Figure 20. Predicted amino acid sequence of the RSS1 gene. The six
conserved helicase motifs (identified by Gorbalenya et al., 1989) are
underlined.

78
amino-terminus outside the central domain from amino acid positions 79 to 86.
A blastp search also revealed that RSS1 shares a strong homology to yeast
SK/2 and several other putative ATP-dependent RNA helicases (Dangel et al.,

1995 and Widner et al., 1993). Interestingly, SK/2 encodes an antiviral protien
that blocks translation of L-A viral RNA.
We also scanned the RSS1 protein sequences for the occurence of
patterns stored in the PROSITE data base via the ExPASy molecular biology
server. Interestingly, ScanProsite revealed the conserved ATP-binding motif as
well as potential glycosylation sites, phosphorylation sites and a putative
leucine zipper pattern. The putative leucine zipper (L-X6-L-X6-L-X6-L), which is
present in many transcriptional regulatory proteins (Hoeffler et al., 1988;
Landschulz et al., 1988; O'Shea et aL, 1989), is located in amino acid positions
1073 to 1094 in RSS1.

11. The Mutation in rss1-1

Which Confers the Suppressor

and Temperature Phenotypes is 'Located Near a Conserved
Helicase Motif That is Proposed for Nucleic Acids Binding

To recover the rss1-1 mutant chromosomal allele for DNA sequence
analysis, we used the gap repair method (Orr-Weaver er al., 1981 ). A gap was
introduced into the centromere-based vector pLIN3A by removing a 3.5kb

Sac 1-Sna Bl fragment (Fig. 21 ). The linearized DNA was then transformed into
the JL2 mutant strain. Repair of the gap using chromosomal sequences as a
template leads to an autonomously replicating plasmid that contains
chromosomal sequences. All transformants exhibited a temperature sensitive
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Figure 21. Recovery of the rss1-1 mutation by the gap-repair
method. A gap was introduced into the centromere-based vector,
pLIN3A, by removing a 3.5-kb Sac 1-Sna Bl fragment. The resulting
plasmid was then transformed into the JL2 mutant strain. The
chromosomal rss1-1 allele was recovered by the plasmid, which
was used as a template for gap repair).
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phenotype indicating that the chromosomal mutations were contained within the
gap. We sequenced the 3.Skb Sac 1-Sna Bl fragment and identified three
mutations. One nucleotide change resulted in Pro to Leu substitution at position
114, a second mutation changed Gly to Arg at position 858, which is near the
conserved GRAGR motif proposed as a nucleic acid binding domain. The third
change is a three base pair deletion eliminating an Asp codon at amino acid
position 240. We weren't sure whether or not all three mutations were
responsible for the suppressor or temperature sensitive phenotypes. We then
recovered the chromosomal allele of the second trans-acting suppressor
isolate. DNA sequence analysis revealed that it contained only a single point
mutation, changing Gly to Arg at position 858. We therefore conclude that this
mutation confers the suppressor and temperature phenotypes in rss 1-1.

D. Discussion

1. Secondary Structures Occuring in Exon 2 Adjacent to a 3'
Splice Site Inhibit Yeast Pre-mRNA Splicing in vivo

Pre-mRNA secondary structure has a significant influence on splice site
selection. While numerous studies have focused upon the splicing inhibitory
effect of hairpins which sequester splice sites, very few have examined the
effect on splicing of secondary structures occuring in exons in the absence of
splice site sequestration. In the current study, we have demonstrated that a
stem-loop structure, formed by a mutant hammerhead, cis-targeted ribozyme
inserted in exon 2 of a yeast ACT-E. coli lacZ fusion gene inhibits both steps of
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the splicing reaction (Fig. 98). We have also observed the same inhibitory effect
on splicing mediated by the antisense sequences of the mutant cis-targeted
ribozyme (data not shown), indicating that the inhibition is due to secondary
structure rather than a specific sequence. A different secondary structure,
formed by an a-nucleotide hairpin, inserted in the same site as the mutant or
antisense ribozyme, was also shown to partially inhibit splicing in vivo (Fig. 15).
These data are consistent with the observations of Dominski & Kole (1994),
who have used antisense 2'-0-methyl oligotibonucleotides to block a number of
sequences in human B-globin pre-mRNA, and demonstrated that at least 25
nucleotides of B-globin exon 2 sequences are required for splicing. Ours is the
first demonstration of exon secondary structures in yeast which blocks splicing.
One of the snRNAs likely to be affected by secondary structure in exon 2
adjacent to the 3' splice site is U5 snRNA. The conserved U5 snRNA loop
sequence has been shown to base pair with exon sequences adjacent to 5' and
3' splice sites (Newman & Norman, 1992; Wyatt et al., 1992; Sontheimer &
Steitz, 1993; Newman et al., 1995). It is possible that single-stranded exon
regions at 5' and 3' splice sites are required for the effective involvement of U5
snRNA. Cellular proteins that interact with the 3' splice site may also be
displaced. Introduction of a strong secondary structure close to a 3' splice site
could sterically hinder the access of trans-acting proteins to the 3' splice site.
Among these factors are Slu7 and Prp8, which have previously been shown to
promote 3' splice site recognition in the yeast Saccharomyces. cerevisiae
(Frank & Guthrie, 1992; Umen & Guthrie, 1995a; Umen & Guthrie, 1995b).
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2. Isolation of Two Cis- and Two Trans-Acting Suppressors
That Alleviate the Block to Splicing

To better understand the influence of pre-mRNA secondary structures on
splice site selection, we have established a genetic screen to isolate cis- and
trans-acting suppressors that restored splicing, thereby allowing expression of
the ACT-mrz-/acZfusion gene. Two trans-acting suppressors were found to
have the same mutation that is responsible for suppressor and temperature
sensitive phenotype. Two cis-acting suppressors were isolated which were able
to partially restore B-galactosidase activity (Fig. 11 A). Sequence data revealed
that both had single mutations in stem Ill of the mutant ribozyme construct
(Fig. 11 B): These mutations could destabilize stem Ill, thereby making 3' splice
site available for recognition. These mutated stems could be further destabilized
by a helicase activity. In supportive of this, a synergistic effect on
B-galactosidase activity (Table 2) and splicing (not shown) was observed when
the cis-mutations were coupled with the rss1-1 mutant allele. This sinergy
suggests that the rss 1-1 mutant allele may be involved in distabilizing the stem
Ill structure, thereby allowing selection of the 3' splice site.

3. The Effects of the rss1-1 Allele on Expression of the
ACT-mrz-/acZ,

ACT-~IVS

and ACT-SL-/acz Genes

The rss1-1 allele increased the steady-state levels of ACT-mrz-/acZ
splicing intermediates (pre-mRNA, lariat intermediate) and enhanced splicing
efficiency at the permissive temperature (Fig. 12). The dramatic increase in
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B-galactosidase activity driven from ACT-mrz-lacZ in contrast to that driven from
ACT-~IVS, the intron-less version of ACT-mrz-/acZ, clearly indicates a

splicing-dependent effect of rss1-1 {Table 1). The potential involvement in
splicing of RSS1 is further implicated by rss1-1 decreasing the splicing
efficiency of ACT-SL-/acZ. In vivo RNA analyses revealed an accumulation of
lariat intermediates and a concomitant decrease of mature ACT-SL-/acZ mRNA
(Fig. 15C and 150).
Our results suggest that a preference of the rss1-1 allele has preference
for some feature(s) of the secondary structure held in common between the
mutant ribozyme and its antisense counterpart. That rss1-1 confers a unique
suppressor phenotype led us to a gain-of-function model for this suppression.
The suppressor mutation(s) may mediate a specific interaction with the mutant
or antisense ribozyme secondary structure and thus stabilize the mutant
ribozyme-containing transcripts, including the splicing intermediates. This
stabilization along with a destabilization of stem Ill would result in increased
spliced product formation.
The specificity of the effect of rss1-1 on expression of the ACT-mrz-lacZ
and ACT-SL-/acZ genes raises the intriguing possibility that the RNA
recognition or binding may be coupled with the other functions of the RSS1
protein.
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4. The rss 1-1 Allele Decreases the Steady-State Levels of the
Wild Type Messages and Creates a Splicing Defect of
Specific lntron(s) at the Nonpermissive Temperature

In an attempt to address the problem of why the trans-acting suppressor
is temperature sensitive, we examined the RNA profiles of three wild type
messages. Our experiments revealed a small but reproducibly detectable drop
in the steady-state levels of ACT, RP51A and CYH2 mature mRNAs at the
nonpermissive temperature (Fig. 16). The rss1-1 allele also increased RP51A
pre-mRNA levels, although to a lesser extent than did prp2-1 (Fig. 168). No
obvious accumulation of either actin or CYH2 pre-mRNAs was observed. This
lack of a general splicing defect does not negate a general and essential role of

RSS 1 in splicing. It is possible that the ASS 1 protein .is multifunctional and that
the particular mutant allele we have isolated does not have a dramatic effect on
splicing. The heterogeneous effects of rss1-1 on pre-mRNA splicing also raises
the possibility that the protein may be involved in splicing of specific introns. The
temperature sensitivity is likely to be the result of a global decrease in mature
mRNAs, severe decrease in a subset of mRNAs, or the accumulation of
pre-mRNA of a specific, essential message at the nonpermissive temperature,
which we have not yet identified.
In conclusion, we have examined the splicing inhibitory effect of an RNA
secondary structure in exon 2 of an ACT-mrz-/acZfusion gene in yeast. We
have isolated and characterized cis-mutations that partially relieve the
secondary structure, thereby partially restoring splicing. We have also identified
a trans-acting suppressor, rss 1-1. rss 1-1 partially restored expression of the
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ACT-mrz-/acZfusion gene by both increasing the steady state levels of
pre-mRNAs, lariat intermediates, and enhancing splicing efficiency. This
suppressor activity seems to be specific for the mutant ribozyme secondary
structure since another artificially introduced secondary structure, which also
blocks splicing, is not suppressed by this mutant allele. We have cloned the
wild-type RSS1 gene. It is a single copy, essential gene and encodes a putative
ATP-dependent RNA helicase with a DEIH box. It is likely to play an interesting
role in RNA processing.

E. Materials and Methods

1. 5. cerevisiae strains

J M43 (MA Ta leu2-3, 112 ura3-52 trp 1-289 his4-580) (kindly provided by
Joan McEwen) was used in the genetic screen for isolating cis- and transsuppressors that could restore B-galactosidase expression. One of the two
temperature sensitive trans-suppressors isolated was crossed with JM19 (MA Ta
ade his4-580) (also kindly provided by Joan McEwen) and the resulting

diploids were sporulated. A temperature sensitive haploid from this sporulation
was backcrossed three times with JM43 to obtain JL2 (MAT trpt-289 ura3-52
his4-580 rss1-1). JL2 was transformed with a YCp50-yeast genomic DNA

library and wild type RSS1 was identified. JL4 was homozygous for RSS1 and
was derived from a cross between JL3 (MATa leu2-3, 112 ade his4-580
trp1-289 RSS1) and JM43. An integrating vector pRS305-3AH3 (see plasmid

construct) containg a deletion-frameshift allele of RSS1 and the LEU2 gene
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was linearized with Bgl II and transformed into JL4 to result in JL5 (MA Ta/a
ade!Ade his4-580/his4-580 trp1-289/trp1-289 ura3-52/Ura rss1:Leu2/RSS1).

Transformations of all yeast strains were performed using the
DMSO-enhanced lithium acetate method (Hill et al., 1991 ).

2. Plasmid constructs

The plasmid pJYH7 contained the ACT-lacZ gene fusion described
previously by Deshler and Rossi, 1991. A mutant cis-targeted ribozyme
(sequence shown in Fig. 28) was cloned into a Sal 1 site 5 nucleotides
downstream of ACT 3' splice site to creat ACT-mrz-lacZ. ACT-AIVS was
constructed by a precise deletion of the intron in ACT-mrz;./acZ A YCp50-yeast
genomic DNA library provided by D. Ho and R.J. Lin was used to transform the
RSS1 temperature sensitive JL2 strain. pLIN3A, the first isolated clone that

complemented the temperature sensitive phenotype of JL2 contained a 11-kb
Sau 3A yeast genomic fragment. A Sac I-Hind Ill fragment which contained the

5' end of the RSS1 ORF was cloned into the yeast integration vector PRS305
resulting in pRS305-3ASH. Targeted integration of pRS305-3ASH into the
chromosome at the RSS1 locus was accomplished by digesting the plasmid
DNA with Bam H1, followed by transformation into a temperature sensitive
haploid strain and selection for Leu+ transformants. For creation of a
deletion-frameshift allele of RSS1, pRS305-3ASH was digested with BamHI
and treated with Mung Bean nuclease. The resulting plasmid pRS305-3AH3
has a single base pair deletion (GGTACC'GTACC) as determined by DNA
sequence analysis.
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3. B·Galactosidase assays

B-Galactosidase assays in liquid culture were performed as described
previously (Reynolds & Lunkblad, 1987). B-Gal yeast colony filter assays were
adapted from Breeden & Nasmyth (1985). Nitrocellulose filters (purchased from
completely. The filters were lifted off the plates and submerged in liquid nitrogen
for 20 seconds to permeabilize the yeast cells. The filters were then carefully
removed from the liquid nitrogen, allowed to thaw with the colony side up for
several minutes, and subsequently laid on Whatman 3MM chromatogtaphy
paper soaked with 0.5mg/ml X-Gal in Z-buffer in a 100x15 mm polystyrene petri
dish (Becton Dickinson). The filters were incubated from 30 minutes to 24 hours
at 37

°c.
4. Total yeast RNA extraction

Total yeast RNA was extracted using a hot acid phenol procedure.
Twenty ml yeast cultures were harvested and suspended in 1 ml of ice-cold
50mM sodium acetate (pH 5.3), 10 mM EDTA. 0.1 ml of 10% SOS were then
added and the cell suspension vortexed vigorously, followed by extraction with
an equal volume of acid phenol (Appligene) at 65 °C for 1min x 4. The mixtures
were chilled in dry ice until phenol crystals appeared. After microcentrifugation,
the aqueous phase was transfered to a new Eppendorf tube and a second hot
phenol extraction was carried out. The aqueous phase was then extracted once
with a 1: 1 mixture of phenol-chloroform at room temperature for 5 min, brought
to 0.3 M sodium acetate (pH 5.3) and 2.5 vol of ethanol were added to
precipitate the RNA
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5. Primer extension, Quantitative RT-PCR, Northern blot
analyses

For primer extension analyses, 1O µg of total yeast RNA were annealed
with 0.5 pmol of 32p end-labeled oligo in 1 x reverse transcriptase (RT) (-Mg)
buffer (0.05M Tris. Cl pH8.3, 0.06M NaCl and 0.01 M OTT). 2 ul of 36mM
Mg(OAc)2 in 1 x RT (+Mg) buffer (0.006M Mg(OAc)2) were added to the
annealing mixture which was then kept on ice. 10 units of reverse transcriptase
in 1 x RT (+Mg) buffer were added to 3 µI annealing mixture and the reaction
was incubated at 47 °C for 45 min. Samples were then subjected to
electrophoresis in denaturing, 6% polyacrylamide gels.
For quantitative RT-PCR analyses, reverse transcription steps were done
as above (except that the oligoes were not 32p end-labeled). The PCRs were
then carried out in a Perkin-Elmer/ Cetus DNA thermal cycler by using the
standard reaction mixtures suggested by the manufacturer. A stepped cycle
program was used. 10, 20 or 30 cycles of 1 min at 94°C, 1 min at 59°C and
1 min at 72°C were carried out and it was maken sure that the amplified DNA
products were not saturated. The DNA products derived were electrophoresed
in an agarose gel, visualized by staining with ethidium bromide, quantitated and
. normalized to ACT1 mRNA by IS-1000 Digital Imaging system (Alpha lnnotech
Corporation). Northern blot analyses were performed as previously described
(d'Orval et al., 1986).
Quantification of ACT1, RP51A and ACT-mrz-lac Z mRNAs and primer
extended cDNAs were accomplished by using a Bio-Rad Phosphor Analyst/PC.
The quantitated products were normalized with U6 snRNA, expression of which
is not affected by the rss1-1 mutant allele.

CHAPTER 4

ADDTIONAL STUDIES OF CIS· AND TRANS-ACTING MUTANTS
AFFECTING 3' SPLICE SITE UTILIZATION

The following unpublished studies include several additional
experiments which extend the findings of Chapter 3.

A.

Phenotype of the Cis-acting Mutation (pCis-31) Can Be

Suppressed By Restoring Base-Pair Complementarity Within the
Ribozyme

We have shown previously that an experimentally introduced secondary
structure in exon 2 adjacent to the 3' splice site of a yeast ACT-E. coli lacZ
fusion gene abolishes splicing in vivo thereby inhibiting p-galactosidase
production (Lin & Rossi, 1996). Two cis-acting mutations that restored splicing,
and consequently p-galactosidase production, were isolated. Sequence data
suggest that both single mutations could disrupt base pairing in stem Ill of the
ribozyme sequence (Fig. 3). To confirm this, we restored sequence
complementarity and determined whether this suppressed the phenotype of the
cis-acting mutation. We created a plasmid construct, p83, bearing both the G to
A mutation in pCis-31 and a compensatory C to T mutation (Fig. 22). The
mutations were created by polymerase chain reaction amplification of the
respective DNAs using primers that contained the desired nucleotide changes.
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Figure 22. Phenotype of the cis-acting mutant (pCis-31) can be suppressed
by restoring complementarity. Only the ribozyme RNAs encoded by the
plasmids are shown. Plasmid pB3, bearing both the G to A mutation in
pCis-31 and the compensatory C to U mutation, inhibits B-galactosidase
expression. Plasmid p11, bearing only the C to U mutation, relieves the
splicing blockage and partially restores B-galactosidase expression. The
mutations in the hammerhead ribozyme are marked with * .
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P-Galactosidase production from p83 was now inhibited as evidenced by a
yeast p-galactosidase colony filter assay. To confirm that the compensatory C
to T nucleotide change alone does not inhibit p-galactosidase production, we
also created a plasmid construct, p11, bearing only the C to T mutation at the
same site (Fig. 22). As expected, the compensatory C to T by itself does not
cause inhibition of p-galactosidase production. Since the base pairing in stem
Ill is disrupted in p11, the C to T mutation restored splicing and p-galactosidase
production.

B.

A More General Phenomenon Of Exon 2 Secondary

Structure-Specific Splicing Regulation

To determine whether the cis-acting mutants isolated from our previous
genetic screen (Lin & Rossi, 1996) represent a more general phenomenon of
exon 2 secondary structure-specific splicing regulation, several other mutations
were introduced into various sites within stem Ill of the ribozyme constructs
(Fig.23). These mutations were created by polymerase chain reaction
amplification of the respective DNAs using primers that contained the desired
nucleotide changes. All of the mutations potentially disrupt base-pairing and
increase the predicted AG of the secondary structures. The effects of these
secondary structure-destabilizing-mutations on the splicing reaction were
assayed using the yeast p-galactosidase colony filter assay. Our results
(Fig. 23) indicate that they all allow reutilization of the nearby splice sites and
increase p-galactosidase production.
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Figure 23. The primary sequence and secondary structure of the artificially
constructed cis-acting mutants. All of the mutations potentially disrupt base
pairing and increase the predicted AG of the ribozyme. The mutations are
marked with *.
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C.

Identification and Characterization of a Third Cis-acting

Suppressor, p18, from the Genetic Screen

We have now identified a third cis-acting suppressor, p18, from the
genetic screen. p18 restored p-galactosidase activity to about 20 units, a level
higher than the previous two cis mutants. We tried to sequence the region
encoding the hammerhead ribozyme using automated ABI PRISM Dye
Terminator Cycle Sequencing Kit (with AmpliTaq DNA Polymerase, FS).
Surprisingly, the sequence could only be read 6-7nt into the ribozyme. It
appears that the processivity of AmpliTaq DNA polymerase (FS) is inhibited.
We determined whether the region could be amplified by PCR using Taq DNA
polymerase. We tried a variety of different schemes, including initial denaturing
at 94°C for 5-10 minutes, and increasing the annealing temperature to 72°C.
We were unable to detect any PCR amplified product.
We then tried to manually sequence the region encoding the ribozyme
using Sequenase 2.0. Although GC compression was encountered,
sequencing from both directions revealed a clear, overlapping primary
sequence of the region. When folded, the region was able to form a 24-nt
stem-loop secondary structure. However, when the reading frame was
checked, we found a putative +1 frameshift within the 24-nt stem-loop
sequence. To examine whether there was a -1 frameshiftearly in the /acZgene
so that lacZ reading frame would be restored, the 24-nt stem-loop sequence
was deleted by digestion with Sal I (which flanks both ends of the 24-nt
stem-loop sequence). The resultant plasmid was tested for its ability to express
p-galactosidase. This plasmid expressed p-galactosidase activity, thereby
ruling out the possibility that there was a -1 frameshift in the lacZ gene.
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Additional experiments are underway to confirm the putative +1 frameshift in the
24-nt stem-loop sequence; and to explore the possibility of ribosome frameshift
. as a result of the secondary structure of p18.
The sequencing data indicates that p18 has a deletion of stem II and part
of the catalytic core of the ribozyme (Fig. 24). The resulting region has the
potential to form a 24-nt stem loop motif, with a LiG very similar to that of the
hammerhead ribozyme.
We have shown previously that the suppressor activity of rss 1-1 is
specific for the secondary structure of hammerhead ribozyme. Since p18
possesses a secondary structure much different from that of the hammerhead
ribozyme, one predicts that suppressor activity would not be observed with p18.
This was confirmed by transformation of p18 into wild-type S. cerevisiae strain
JM43 and the mutant strain JL2. Comparison of the f3-galactosidase activities
driven from these transformants indicated that the mutant rss1-1 strain does not
up-regulate f3-galactosidase expression from p18.

D.

Attempts To Identify Protein Factors That Interact With The

RSS1 Protein

To further elucidate the essential cellular function of the RSS1 protein,
we have attempted to identify genes encoding protein factors that interact with
the RSS1 protein. We have taken two approaches, genetic and physical.
We have isolated 25 naturally occuring revertants that can suppress the
temperature-sensitive phenotype of the rss1-1 mutation. These revertants,
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Figure 24. The putative primary sequence and secondary structure of the
ribozyme RNA encoded in plasmid p18. As shown here, p18 could result
from pJYH7-mrz deletion of nucleotides encoding part of the ribozyme
(ribonucleotides in the dashed triangle).
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which are Ts+ Ade+ Ura-, were crossed with a RSS1 strain that was
Ts+ Ade- Ura+. Tetrad analyses were then performed. If the revertants were
intragenic suppressors, all four spores would be Ts+. If the revertants were
extragenic suppressors (i.e. mutant interacting proteins), at least some of the
spores would be ts-. Our results indicated that all 25 revertants were intragenic
suppressors.
A physical approach for identifying protein factor( s) that interact with
RSS1 takes advantage of the yeast two hybrid system. In preparation for this, a
1.5kb Pst1-Pst1 fragment of the RSS1 gene was cloned in frame with the yeast
GAL4 DNA binding domain in pBTM116, resulting in pBTM3AP. Future
experiments in the laboratory include screening a yeast GAL4 activation
domain-genomic DNA library for genes encoding proteins that interact with the
RSS1 protein. It is beyond the scope of this thesis to initiate the screening step
and analyze the clones selected by the interaction between the GAL4 domains.

E. rss 1-1 Does Not Affect The mRNA Stability Of Wild type
Messages

We have shown that the rss-1 allele decreases the steady-state levels of
wild-type messages at the restrictive temperature. Our data support the
interpretation that the decrease is due to inefficient splicing. We have also
examined the possible role of rss1-1 in mRNA stability. We followed the decay
rates of ACT1 and RP51A transcripts via Northern blot analyses following
treatment of the cells with the transcriptional inhibitor 1, 10-phenanthroline. Our
results did not suggest any dramatic difference between the decay rates in wild
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type JM43 cells and the ones in mutant JL2 cells (over a time period of
90 minutes). These results further support an interpretation that rss1-1
decreases the steady-state levels of wild type messages by lowering the
efficiericy of splicing.

CHAPTER 5

DISCUSSION

A. Historical Perspective

Obscure and unlikely connections can often lead to unexpected findings.
In 1989, Dr. John Rossi initiated a project to develop anti-HIV-1 ribozymes. The
objectives were to: (1) develop and employ a yeast (Saccharomyces
cerevisiae) expression system in which ribozyme activity can be readily
monitored via cleavage of a chimeric S. cerevisiae ACT-E. coli lacZ fusion
mRNA; and (2) utilize the genetic attributes of the yeast (Saccharomyces
cerevisiae) to identify critical variables leading to enhanced stability and
catalytic activity of anti-HIV-1 ribozymes. During the course of the project, a
splicing-related enigma was observed. The cis-acting hammerhead ribozyme,
inserted 5-nt downstream of the ACT 3 1 splice site in the chimeric yeast
ACT-E. coli lacZfusion gene, virtually abolished splicing in vivo. This behavior
of the hammerhead ribozyme appeared to be related to its RNA secondary
structure since the antisense or mutant ribozymes, which have the same
secondary structure, but different primary sequences, similarly inhibited
splicing.
Numerous studies have focused upon the inhibitory effect on splicing of
hairpins that sequester splice sites, while very few have examined the effect on
splicing of secondary structures occurring in exons in the absence of splice site
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sequestration. The behavior of the hammerhead ribozyme (described above) is
particularly interesting because the ribozyme secondary structure occurs in
exon 2 without sequestering the 31 splice site per se. This thesis project was
designed to further investigate the effect of RNA secondary structure of exon 2
on pre-m RNA splicing. We took the approach of genetic suppression, isolating
yeast mutants which would alleviate the splicing blockage exerted by the
hammerhead ribozyme. The study was divided into characterization of:
( 1) cis-acting mutants and (2) trans-acting mutants.

B. Characterization of BothCis- and Trans-Acting Mutants

1. Exon 2 Secondary Structure-Specific Splicing Regulation

Sequencing of the two cis-acting mutations isolated revealed that both
had single-base alterations in the 10-nt stem Ill of the mutant ribozyme
construct. The predicted secondary structure of both cis-acting mutants is less
stable. The two cis-acting mutants partially restore splicing, as evidenced by
increased (3-galactosidase expression. Our working hypothesis is that a
specific region of exon 2 needs to be single-stranded for efficient splicing; a less
stable secondary structure could be more easily unwound by a cellular
helicase, allowing recognition of the 3' splice site. To test this hypothesis, we
introduced other mutations into the stem Ill of the ribozyme construct. Each of
the mutations disrupts base-pairing and decreases the stability of the ribozyme
structure. All of the ribozyme mutant constructs tested partially restored splicing,
as evidenced by increased (3-galactosidase expression. Finally, our
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hypothesis was strengthened by the fact that increasing the stability of the RNA
structure by restoring complementarity suppresses the ~-gal+ phenotype of the
cis-acting mutants.
Our results with the cis-acting mutants isolated from the genetic screen
and the site-specific mutants constructed later indicate that there might be a
general phenomenon of exon 2 secondary structure-specific splicing regulation.
Dominski and Kole (1994) have used antisense 2'-0-methyl
oligoribonucleotides to block a number of sequences in human

~-globin

pre-mRNA. They demonstrated that at least 25-nt of ~-globin exon 2
sequences are required for splicing. Our project is the first such demonstration
of exon secondary structures blocking splicing in yeast. Secondary structure in
exon 2 might interfere with pre-mRNA interaction with snRNAs or protein factors.
One of the snRNAs likely to be affected by secondary structure in exon 2
adjacent to the 3' splice site is U5 snRNA. The conserved U5 snRNA loop
sequence has been shown to base pair with exon sequences adjacent to 5' and
3' splice sites (Newman & Norman, 1992; Wyatt et al., 1992; Sontheimer &
Steitz, 1993; Newman et al., 1995). Cellular protein factors that are likely to be
displaced by secondary structure in exon 2 include Slu7 and Prp8, which have
been shown previously to promote 3' splice site recognition in the yeast

S. cerevisiae (Frank & Guthrie, 1992; Umen & Guthrie, 1995a, 1995b).
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2. RSS1 Is a Single Copy, Essential Gene and Encodes a
Putative ATP-Dependent RNA Helicase

We have independently recovered two trans-acting mutants. Both were
found to have a mutation in the same gene. The wild-type RSS1 gene was
subsequently cloned by complementation of the mutant allele. RSS1 is a single
copy, essential gene located on Saccharomyces cerevisiae chromosome V. It
has a single open reading frame of 6,492-nucleotides that could encode a
264.2 kDa protein. Comparison of the deduced amino acid sequence with the
protein data base using Blastp revealed that the ASS 1 protein possesses a
central region of approximately 357 amino acids containing six conserved
· motifs found in ATP-dependent DNA and ANA helicases (Gorbalenya et al.,
1988, Gorbalenya et al., 1989). This adds a new member to the perhaps most
exciting group of yeast helicase-like PAP proteins which participate in the
splicing pathway. This group includes the DEAH-box proteins (PAP2, PRP16,
and PAP22), and the DEAD-box proteins (PAPS and PAPS). ASS1 is the sixth
and largest of this group, it is a DEIH-box protein.

3. Role of ATP-Dependent RNA Helicases in Splicing

Pre-mRNA splicing requires ATP hydrolysis. Yet, there is no net change
in the number of phosphodiester bonds in the spliced products. Identification of
the helicase-like yeast factors in the splicing pathway has helped to decipher
the highly dynamic, ATP-consuming process of splicing. It is postulated that
these ATP-dependent RNA helicases utilize the energy derived from ATP
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hydrolysis for one or both of the following functions: first, facilitating the dynamic
RNA-RNA interactions in the spliceosome, or second, proof-reading the correct
conformations to determine the fate of splicing intermediates (either productive
splicing or discard). Although no RNA helicase activity has been reported for
any of the above proteins, the RNA-dependent ATPase activity of PRP2 and
PRP16 has been demonstrated in vitro (Schwer & Guthrie, 1991; Kim et al.,
1992). Moreover, the ATP hydrolysis of PRP2 and PRP16 is accompanied by a
conformational rearrangement in the spliceosome (Schwer & Guthrie, 1991;
Kim et al., 1992).

4. Dominant Suppressor Phenotype vs Recessive
Temperature Sensitive Phenotype

The suppressor phenotype of rss1-1 is dominant over the wild-type
RSS1 as judged by the increased p-galactosidase from ACT-SL-/acZ in the

heterozygous diploid. The temperature-sensitive phenotype of rss1-1 is
recessive as judged by the growth of the heterozygous diploid at the
nonpermissive temperature (37°C). This finding shows that the
temperature-sensitive phenotype is not required for suppression and that
suppression does not lead to temperature sensitivity. The step at which
suppression function acts is separable from the step at which
temperature-sensitivity results.
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5. Allele Specificity of the Trans-Acting Suppressor
Phenotype

The two trans-acting mutants were found to have the same nucleotide
change in the same gene, indicating allele specificity of the mutant protein. The
trans-acting suppressor activity is specific for the secondary structure of the

hammerhead ribozyme rather than primary sequence. This is supported by the
following: (1) the trans-acting suppressor is able to restore (3-galactosidase
expression to the same level from the ribozyme, mutant ribozyme, and
antisense ribozyme constructs (all of which share the same overall RNA
secondary structures); (2) the trans-acting suppressor is also able to restore
(3.,-galactosidase expression from the cis-acting mutants 31 and 38, which have
similar secondary structures to the hammerhead ribozyme; (3) the trans-acting
suppressor is not able to restore (3-galactosidase expression from
ACT-SL-/acZ, an 8-nt hairpin construct; and (4) the trans-acting suppressor is
not able to restore (3-galactosidase expression from p 18, a 24-nt hairpin
construct.

6. Effects of the rss1-1 Allele on Expression of the
ACT-mrz-/acz, ACT-AIVS, and ACT-SL-/acZ Genes

The rss1-1 allele increases the mature mRNA level of ACT-mrz-/acZas
demonstrated by RT-PCR analyses. This suggests a splicing enhancement
effect of rss1-1 on ACT-mrz-/acZ The dramatic increase in (3-galactosidase
activity from ACT-mrz-/acZin contrast to that from ACT-AIVS, the intron-less
version of ACT-mrz-/acZ, suggests a splicing-dependent effect of rss1-1. The
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involvement of RSS1 in splicing is further implicated by rss1-1 decreasing the
splicing efficiency of ACT-SL-/acZ
In the presence of the rss1-1 allele, an increase in the mature mRNA
level of ACT-mrz-lacZ is not accompanied by a concomitant decrease in the
amount of pre-mRNA and lariat intermediate. In fact, we observed a significant
increase in pre-mRNA and lariat intermediate. The overall RNA levels, the sum
of precursor, lariat intermediate, and mature RNA, are increased. We have
demonstrated that rss1-1 has no effect on pre-mRNA or lariat intermediate
levels of the endogenous ACT1 gene, which utilizes the same promoter as
ACT-mrz-/acZfusion gene. Although definitive proof relies on a nuclear runoff
assay, our current data does not suggest that rss1-1 increases the levels of
pre-mRNA and lariat intermediate by upregulating transcription. We therefore
hypothesize that

rss 1-1 might promote stability of the pre-mRNA and

lariat

intermediate of ACT-mrz-lacZ

7. BRR2, SLT22, Snu246p

During the past year, isolation of the RSS 1 gene has been reported by
three other laboratories, using three different strategies. First, Noble & Guthrie
(1996) identified a cold-sensitive splicing-defective mutant, brr2-1, which
accumulates both pre-mRNAs and lariat intermediates when shifted to 16°C.
This phenotype suggests that the BRR2 protein might function in one of the
spliceosome assembly steps prior to the first catalytic reaction. Second, Xu et
al. (1996) isolated slt22-1 in a genetic screen for synthetic lethality with a mutant
U2 snRNA that could potentially perturb U2/U6 helix II interaction. The SLT22
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protein has in vitro ATPase activity and the rate of ATP hydrolysis is stimulated
by the correct RNA substrate. The ATPase activity was preferentially stimulated
by annealed wild-type U2/U6 snRNAs. The mutant U2 snRNAs were less
efficient in stimulating the ATPase activity of SLT22. The mutant slt22 protein
exhibited less ATPase activity than the wild-type protein in the presence of wild
type U2/U6 snRNAs. And third, Lauber et al. (1996) identified Snu246p as a
homologue to the HeLa U5-200kD protein. Like its mammalian counterpart,
Snu246p is a US snRNP-specific protein. U4, US and U6 snRNAs can be
co-immunoprecipitated from yeast splicing extracts containing an HA-tagged
derivative of Snu24Sp with HA-tagged specific antibodies. Lauber and
colleagues believe Snu246p is an integral component of the US snRNP.

8. The GRAGR Region Is Likely to Be Involved in RNA Binding

The suppression

o! the hammerhead ribozyme splicing inhibition by

rss1-1 and the synthetic lethal effect of slt22-1 with a mutant U2 snRNA suggest
that both mutations alter the RNA binding substrate of the protein. The rss1-1
mutation alters a residue that is 1S amino acids from the GRAGR sequence
(Fig. 2S). The slt22-1 mutation alters a residue that lies 32 amino acids from the
GRAGR sequence. The fact that the two mutations are in close proximity to the
conserved GRAGR helicase motif suggests the GRAGR region may be involved
in RNA substrate binding. This is consistent with the observation of Pause et al.
(1993) that mutations in the HRIGRAGR sequence drastically reduce elF-4A
cross-linking to RNA. In addition, some of these mutations affect ATP binding
and ATPase activity, suggesting a coupling of ATP hydrolysis and RNA binding.
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Figure 25. Schematic of the RSS1 protein. The mutations in rss 1-1 and
slt22-1 are shown.
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9. Models for rss1-1 Suppression of the Splicing Block Exerted by
the Hammerhead Ribozyme

Analysis of the trans-acting mutants suggests two models for rss1-1
suppression of the splicing block exerted by the hammerhead ribozyme:

Model I (Gain of Function)

The wild-type Rss1 protein might recognize U2/U6 snRNA helices
(Fig. 26). Possibly the mutant rss1-1 protein is able to recognize the
hammerhead ribozyme, whose secondary structure bears similarity to the
U2/U6 helices (Fig. 27). The rss 1-1 probably does not recognize any other
secondary structure (eg., 8-nt hairpin) since the suppressor activity is only
observed with the ribozyme constructs (see 3.C.6).
Upon recognition of the hammerhead ribozyme, rss1-1 may be able to
unwind the secondary structure of the hammerhead ribozyme. This might allow
the region nearby to the 3' splice site to become single-stranded and, therefore,
accessible to the splicing machinery. Suppression is achieved by increased
splicing efficiency.
Upon recognition of the hammerhead ribozyme, it is also possible that
rss1-1 may stabilize the pre-mRNA and lariat intermediate of ACT-mrz-/acZ

(see 5. B.6), and, like prp 16-1, rescue aberrantly formed lariat intermediates
from a degradative discard pathway that branches from the normal splicing
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Model I

~RSS1

~After mutation of RSS1 to rss 1-1
rss1-1

ATP=>~RNA unwinding

ADP+Pi

~rss1-1
OD

Figure 26. Schematic representation of model I for rss1-1 suppression of
splicing blockage. In this model, the rss1-1 protein has gained the ability to
recognize the hammerhead ribozyme. Upon recognition, rss1-1 is able to
exhibit helicase activity and unwind the secondary structure of the
hammerhead ribozyme. This allows the region nearby the 3' splice site to
become single-stranded and, therefore, accessible to the splicing
machinery.
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Figure 27. Secondary structure comparisons of cis-hammerhead
ribozyme and U2/U6 snRNAs. Extensive similarity is observed. Both
have three stem regions (left, upright, and right) and a core region in the
center that is not paired.
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pathway (Burgess & Guthrie, 1993). We may be able to test this by compairing
the stability of the ACT-mrz-lacZ pre-mRNA and lariat intermediate in the RSS1
and rss1-1 background.
The gain of function of rss1-1 to recognize the hammerhead ribozyme
can be tested two ways: First; one can .. examine ATPase activity (measured by
release of free phosphate from ATP hydrolysis) of the mutant or wild-type
protein in the presence of the hammerhead ribozyme or U2/U6 snRNA. Since
the rate of ATP hydrolysis of an RNA helicase is presumably stimulated by its
correct RNA substrate (Burgess et al., 1990; Xu et al., 1996), the prediction is
that ATPase activity of the mutant rss1-1 protein would be preferentially
stimulated by the hammerhead ribozyme, whereas ATPase activity of the wild
type protein would be preferentially stimulated by U2/U6 snRNAs. Second, it is
possible that the mutant rss1-1 protein could physically associate or bind to the
hammerhead ribozyme while the wild-type protein could not. We could test this
by means of gel shift or crosslinking analyses.

Model II (Loss of Function)

The wild-type RSS1 protein might recognize both U2/U6 helices and
hammerhead ribozyme secondary structures (due to the high similarity between
them) (Fig. 27 & Fig. 28). Inhibition of ACT-mrz-/acZ splicing could be due, not
only to the secondary structure of the hammerhead ribozyme, but also steric
interference of the bulky RSS1 protein-hammerhead ribozyme RNA complex
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Model II

RSS1

R

After mutation of RSS1 to rss1-1

~

rss1-1

Figure 28. Schematic representation of model II for rss 1-1 suppression of
splicing blockage. In this model, the wild-type RSS1 protein recognizes
the hammerhead ribozyme secondary structure. Inhibition fo splicing is
not only due to the secondary structure of the hammerhead ribozyme, but
also due to steric interference of the bulky RSS1 protein-hammerhead
ribozyme RNA complex blocking the nearby 3' splice site. We have
mutated the protein so that rss1-1 cannot bind to the hammerhead
ribozyme. This partially alleviates the splicing blockage.
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blocking the nearby 3' splice site. In this model the rss1-1 protein would not
bind to the hammerhead ribozyme. The consequence of this may be that
splicing blockage is partially relieved, although never fully, since splicing is still
inhibited by the secondary structure of ribozyme.
The second model predicts. that an equally stable, but .different secondary
structure would not block splicing as much as the hammerhead ribozyme. This
is because splicing would only be inhibited by the effect of the secondary
structure but not the bulky protein-RNA complex. This is supported by our
results with the third cis-acting mutant p18, which has the potential to form a
24-nt stem loop motif, and has a AG very similar to that of the hammerhead
ribozyme. The second model could also explain the allele specificity of rss1-1.
Neither wild-type nor mutant protein might recognize any secondary structure
other than the U2/U6 or hammerhead ribozymes. Therefore, trans-acting
suppressor activity is only observed with the hammerhead ribozyme, but not
with other secondary structure constructs that we tested (see 3.C.6 & 4.C.). We
can test model II by testing whether the hammerhead ribozyme binds to or
crosslinks with the wild-type Rss1 protein, but not the mutant rss1-1 protein.
During our genetic screen for suppressors of splicing inhibition, we
independently identified rss 1-1 twice. This suggests that the rss 1-1 allele is
highly specific for what we have asked the cell to accomplish, survival and
suppression of the ribozyme. RSS1 is an essential gene. Only a small number
of changes may be tolerable. Among them, only one may allow rss1-1 to gain a
specific activity to recognize the secondary structure of the hammerhead
ribozyme (model I). Alternatively, only one may allow rss1-1 to lose the ability to
bind to the hammerhead ribozyme (model II) without knocking out its essential
function.
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C. Implication of Hammerhead Ribozyme Studies in Yeast

In the past, we have tried virtually every scheme possible to get
hammerhead ribozymes to function in yeast. We have expressed the ribozymes
under various promoters, including inducible GAL, U2 snRNA, or-the very strong
RNAseP-RNA Pol Ill promoter. We have also positioned the ribozymes in a
variety of locations in several different transcripts. We have attempted
co-localization strategies, designed to maximize effective interactions of
ribozymes and target RNAs. We have utilized very sensitive assay systems,
including B-galactosidase screening and positive selection for resistance to
alpha aminoadipate. In spite of this immense effort, we have not been able to
demonstrate hammerhead ribozyme cleavage of target RNA in yeast.
There are several potential reasons why the ribozymes fail to cleave
target RNA in yeast. One of them is that the ribozymes might not fold in the
correct conformation. The isolation of the cis-suppressors suggests that at least
the stem Ill secondary structure of the mutant ribozyme is present. Since
cis-mutations disrupt the base pairing in stem Ill of the mutant ribozyme, we
believe that stem Ill was able to form and inhibit splicing to the adjacent 3' splice
site in vivo.
Failure to detect ribozyme activity in yeast has also been related to
protein- mediated inhibition of ribozyme function. In the second model that we
proposed for the trans-acting suppressor activity, the wild-type Rss1 protein
would bind to the hammerhead ribozyme. We considered the possibility that
Rss1 might inhibit ribozyme function in yeast. Since the second model predicts
that mutant rss1-1 protein does not bind to the hammerhead ribozyme, we
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examined the ribozyme cleavage activity in rss1-1 yeast cells. Our result
revealed no ribozyme cleavage in rss1-1 yeast cells. Future testing of other
mutant alleles of RSS1 will be necessary to confirm that the Rss1 protein does
not mediate inhibition of ribozyme function in yeast.

D. Future Directions

Two models for rss1-1 suppression of the splicing blockage were
proposed in this dissertation. Future testing of the models will yield insight
concerning how specific RNA structure recognition is associated with its
biochemical activities (such as ATP hydrolysis and RNA unwinding).
None of the five yeast PAP proteins involved in splicing has been
demonstrated an RNA unwinding activity in vitro. It is possible that these
splicing factors may only unwind specific RNA substrates. We have shown in
our system that rss1-1 might unwind the secondary structure of the ribozyme.
Unless other auxiliary protein factors are required for this activity, we may be
able to demonstrate unwinding of the ribozyme by rss 1-1 in vitro.
Our experimental system, in which the RNA secondary structure
encoding sequences are cloned immediately adjacent to the 3' splice site of the
ACT-/acZfusion gene, may serve as an in vivo test tube for assaying the
helicase activity and determining the RNA substrate of the Rss1 protein. The
level of lacZ expression depends upon the splicing of the ACT intron, which in
turn, relies upon the helicase activity of the protein. It has been suggested that
the helicase activity of a putative RNA helicase is coupled with its correct RNA
substrate recognition (Fuller-Pace, 1994). We can then determine the RNA
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substrate of Rss1 by measuring the lacZ expression. Xu et al (1996)
demonstrated via synthetic lethality that U2/U6 snRNAs may be the target of the
RSS1 protein. To further investigate this, we can synthesize a DNA fragment,
which when transcribed, could potentially fold into the U2/U6 helices. We can
then clone this U2/U6 hybrid DNA fragment adjacent to the 3' splice site of the
ACT-/acZfusion gene and assay for the level of lacZ expression in the RSS1 or
rss1-1 background. If U2/U6 is the correct substrate of RSS1 protein, the
secondary structure would be unwinded, splicing would not be inhibited, and
/acZwould be expressed. Moreover, we could determine the region of U2/U6
snRNAs that is critical for its interaction with the Rss1 protein by generating a
pool of randomly mutagenized U2/U6 hybrid DNA fragments in vitro. We could
then clone these fragments immediately adjacent to the 3' splice site of a fusion
ACT-URA3 gene. This fusion gene would be similar to the ACT-lacZ except that

lacZ is replaced by the yeast URA3 gene. Any mutation taking place in the
region of U2/U6 that may be critical for Rss1 interaction would cause the Rss1
protein not able to unwind the secondary structure of U2/U6 helices. Splicing
would be inhibited and URA3 gene expression would be repressed. This
allows the selection of yeast cells that contains the mutant construct on 5-FOA
medium.

CHAPTER 6

SEARCH FOR MAMMALIAN BINDING PROTEINS THAT INTERACT
WITH HIV-1 CRS, INS-1, AND TAR RNA ELEMENTS

A. INTRODUCTION

1. HIV CRS, INS-1, and TAR

Investigation of the human immunodeficiency virus (HIV) life cycle has
revealed a complex pattern of gene expression. The expression of all the HIV
genes from one promoter is accomplished by the generation of alternatively
spliced mRNAs grouped into three size classes: full length, intermediate, and
small (Muesing et al., 1985; Schwartz et al., 1990). Early in the HIV life cycle,
the full length and intermediate RNAs encoding the structural proteins (Gag,
Pol, and Env) appear to be sequestered within the nucleus; the multiply spliced,
short RNAs are efficiently transported to the cytoplasm in the absence of Rev
(Emerman et al., 1989; Hadzopoulou-Cladaras et al., 1989; Hammarskjold et
al., 1989; Malim et al., 1989). Later in the HIV life cycle, expression of Rev
promotes export from the nucleus of full length and intermediate RNAs and
subsequently permits synthesis of the viral structural proteins (for reviews,
Cullen & Greene, 1989; Pavlakis & Felber, 1990; Rosen & Pavlakis, 1990).
Using a heterologous beta-globin system, Chang and Sharp (1989) have
shown that a non-HIV mRNA can be made Rev-responsive by adding both
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Rev-responsive element (RRE) (cis-acting Rev targeting sequence) and a
mutation of either the splice donor or acceptor site of the intron. This led to the
hypothesis that sequestration of HIV structural mRNA in the nucleus is due to
the inefficiency of the splicing reaction.
However,. other studies have found that additional elements present
within the HIV genome contribute to sequestration of mRNA for HIV structural
proteins in the nucleus. Using a heterologous system, Rosen et al. (1988) have
demonstrated that several regions within env contain negative regulatory
elements. These elements, when present within the 3' UTA of a reporter gene
(CAT), block gene expression. In addition, negative effect of these sequences
is relieved by addition of Rev protein in trans. Deletion of them resulted in an
increase in CAT gene expression. Further examination of gag and pol genes
revealed that both genes also contain cis-acting repressive sequences (CRS).
CRS blocks gene expression when present within the 3' UTR of a heterologous
gene transcript (Cochrane et al., 1991). A 490-bp region in pol was found to
have the strongest repressive effect. Deletion mutagenesis defined a minimal
270-bp element within the 3' portion of pol that was capable of inhibiting gene
expression to a similar extent as that observed with the 490-bp fragment.
Incubation of RNA corresponding to the 270-bp CRS element with nuclear
extract prepared from human T-cells reveals a strong and specific interaction
with several cellular factors (Olsen et al., 1992). Monoclonal antibody raised
against hnRNP C reacted with the CRS RNA-protein complex, suggesting that
hnRNP C (or a closely related gene product) interacts with CRS. This finding
raised the possibility that the CRS elements elicit nuclear entrapment of viral
RNA through formation of RNA-protein complexes that are not accessible to
nuclear export pathways.
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Schwartz et al. (1992) identified a 218-bp fragment in the HIV genome,
referred as INS-1 (inhibitory sequences), which has a similar inhibitory effect as
the CRS elements. INS-1 repressed heterologous gene expression when
present in cis. The inhibitory effect of INS-1 was counteracted by the positive
effect mediated by the Rev-RAE interaction.
TAR is the cis-acting sequences that interact with the regulatory Tat
protein (Rosen et al., 1985). It is required for Tat trans-activation of HIV gene
expression. TAR RNA is present in the 5' UTA of all HIV-1 mRNAs. It forms a
stable stem-bulge-loop structure (Muesing et al., 1987). Mutations that disrupt
the stem, affect the loop or bulge, or destroy the overall secondary structure of
the RNA interfere with Tat trans-activation (Feng & Holland, 1988; Roy et al.,
1990).
Several lines of evidence suggest that the direct interaction between Tat
and TAR constitutes only one of the components involved in the overall Tat
trans-activation. The most siginicant of these is the finding that the mutations to
the terminal loop of TAR that strongly inhibit in vivo function have little or no
effect on in vitro Tat binding (Dingwall et al., 1989). It therefore appears that
cellular factors probably cooperates with Tat in the overall trans-activation
process.

2. Translation Initiation

The translation of the vast majority of cellular mRNAs is initiated by a
number of consecutive biochemical reactions. The first protein to bind to mRNA
appears to be elF-4F, a heterotrimer composed of elF-4E, elF-4A, and p220.
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el F-4E is a 24-kD polypeptide which specifically interacts with the m7 G cap
structure at the 5' end of eukaryotic mRNA (8annerjee 1980). Following the
binding of elF-4F to the cap structure of the mRNA, elF-48 associates with
elF-4F. elF-48 is thought to cooperate with elF-4A in RNA binding and stimulate
the helicase activity of elF .. 4A. elF-4A, ·the prototype of the DEAD box RNA
helicases, is an RNA-dependent ATPase. It is thought to use the energy
derived from ATP hydrolysis to unwind potential secondary structures in the
5' UTA. The next step is the binding of the mRNA to the 438 initiation complex,
which is composed of elF-2, GTP, initiator Met-tRNA, and 40 8 ribosomal
subunit. The 43 8 initiation complex scans along the 5' UTA. Local RNA
secondary structure is relaxed during scanning, if it is not, it impedes the
movement of the ribosome on the mRNA. Once an appropriate match is made
between the anticodon of the initiator tRNA and the AUG start codon, GTP is
hydrolyzed. Release of the initiation factors from the surface of the 408 subunit
allows for 608 ribosomal subunit to join.

3. Regulation of Translation Initiation

Initiation is the rate limiting step of translation (Jagus et al., 1981 ). It has
emerged as an important step in the regulation of specific genes in both
prokaryotic and eukaryotic organisms (8onerberg, 1988). Translation of
specific genes can be regulated through particular features of secondary
structure of their mRNA transcripts.
In eukaryotes, the best characterized example of gene regulation by
translational initiation is the protein-RNA interaction of ferritin mRNA. Ferritin
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synthesis is maintained at a very low basal rate when extracellular iron levels
are low. The switch to iron-rich medium induces up to a 50-fold increase in
ferritin translation, with little or no change in the level of the mRNA. All ferritin
mRNAs thus far examined contain a conserved stem loop motif, called IRE
(iron-responsive element). IRE is required in cis .for translational control of
ferritin expression (Caughmann et al., 1988; Hentze et al., 1987a). A
heterologous mRNA is rendered iron responsive when IRE is cloned into the
5' UTR region, suggesting that the presence of an IRE in the 5' UTR is sufficient
for regulation (Hentze et al., 1987b). In vitro studies suggest that IRE serves as
the binding site for a 90-kD cytoplasmic binding protein referred to as the
IRE-BP (iron-responsive element-binding protein) (Rouault et al., 1988). The
IRE binding activity of IRE-BP correlates with the iron status of the cell
(Haile et al., 1989): IRE-BP extracted from cells treated with an iron chelator has
significantly higher affinity for the IRE than IRE-BP extracted from cells treated
with iron
IRE-BP/IRE may sterically block one or more early steps of translation
initiation, thereby repressing translation. Thus, IRE-BP/IRE may represent the
first physiological example of a more general mechanism for translational
blockage imposed by the RNA/protein complex. This hypothesis was tested by
inserting high affinity RNA-binding sites for the bacteriophage MS2 coat protein
or the spliceosomal protein U1A into the 5' UTR of capped chloramphenicol
acetyltransferase(CAT) transcripts (Stripecke & Hentze, 1992). In the absence
of these RNA-binding proteins, CAT mRNA is efficiently translated. Addition of
purified MS2 coat protein or U1A spliceosomal protein causes repression of
CAT synthesis in rabbit reticulocyte and wheat germ in vitro translation systems.
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The translational repression is dosage dependent and could be relieved by
removal of repressor.

4. Objectives

This study was divided into two parts:

I. Identify mammalian protein factor(s) that bind to HIV CRS or
INS-1
There has been much interest in why HIV structural genes are not
expressed in the absence of Rev protein early in the viral life cycle. It has been
proposed that inefficient splicing of HIV mRNA contributes to nuclear
sequestration of full length or intermediate transcripts encoding the structural
proteins. It has also been proposed that nuclear retention of HIV RNA was
mediated by cis-acting repressive sequences or inhibitory sequences. Recent
studies have identified a 270-bp CRS element in the pol gene and a 218-bp
INS-1 element in the 5' end of gag gene. Both have the ability to repress
heterologous gene expression when present in cis. It is thought that they
function through formation of RNA-protein complexes that are not accessible to
nuclear export pathways.
We decided to use a genetic approach to identify protein factor(s) that
may bind to CRS or INS-1 element. We used a counterselectable yeast gene
URA3, whose expression causes toxicity in the presence of 5-FOA
(5-Fluoroorotic acid). We fused HIV CRS or INS-1 elements in cis with yeast
URA3 transcripts (Fig. 29). S. cerevisiae cells were transformed with a
mammalian cDNA library. If a protein factor (encoded by mammalian cDNA)
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Figure 29. 'Strategy to clone HIV-1 CRS or INS-1 RNA binding proteins.
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binds to CRS or INS-1 elements, transcripts will be retained within the nucleus.
URA3 gene expression will be inhibited. Yeast transformants deficient in URA3
gene expression will be positively selected by 5-FOA resistance.

II.

Develop a general technique to clone protein factor(s} that

interact with an RNA fragment of interest
Translation initiation requires scanning of 40S ribosomal subunit along
the 5' UTR of mRNAs until the first AUG is reached. Moderately stable
secondary structures in the 5' UTR can be relaxed by translation apparatus,
ensuring efficient scanning of the 40S ribosomal subunit. However, if the
secondary structure is bound to protein(s) to form an RNA-protein complex,
translation initiation could be sterically blocked. The translation blockage
imposed by an RNA/protein complex has been examplified by IRE/IRE-BP and
several experimental systems.
We decided to use these informations to construct a system that would
allow us to clone protein factor(s) which interact with an RNA fragment of
interest (Fig. 30). An RNA fragment of interest was placed into the 5' UTR of
yeast URA3 gene. If a protein factor encoded by mammalian cDNA binds to the
RNA fragment and form a stable RNA-protein complex, translation initiation will
be sterically blocked. URA3 gene expression will be inhibited. Yeast
transformants deficient in URA3 gene expression will be seclected by 5-FOA
resistance.
We were interested in identifying cellular factor(s) that bind to HIV TAR.
We cloned TAR into the 5' UTR of the yeast URA3 gene, transformed the yeast

125

!

RNA unwinding

!

No RNA unwinding

U RA3 gene expression
5-FOA sensitivity

!
No URA3 gene expression
5-FOA resistance

Figure 30. Strategy to clone protein factor(s) that interact with an
RNA fragment of interest.
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cells with a mammalian cDNA library, and selected for transformants whose
URA3 gene expression was inhibited {5-FOA resistance) as in the first part of
this study. Translation blockage could resulted from a RNA {TAR)/protein
complex.

B. RESULTS

1. HIV-1 INS and CRS Binding Proteins

The 218-bp INS-1 fragment derived from pBKBH10S by polymerase
chain reaction, was first inserted -30 bp upstream of the URA3 start codon in
plasmid p810. The 270-bp CRS fragment kindly provided by Craig Rosen, was
inserted into the same site in URA3 in an analogous construct. We performed a
Northern blot analyses to confirm that INS-1 (and CRS) was in the 5' UTA
region of the URA3 transcript. We were not able to demonstrate that
random-primed labelled INS-1 or CRS probes hybridized to the respective
URA3 transcripts (data not shown)
As an alternative approach, INS-1 or CRS fragments were each inserted
-30-bp downstream of the URA3 termination codon in p81 O plasmid.
Subsequent northern blot analyses showed that at least the INS-1 fragment
was present in cis with the URA3 mRNA. JM43 cells harboring either
p810-CRS or p810-INS were transformed with a rat brain cDNA library (cloned
into yeast expression vectors) (Colicelli et al., 1989). The cells were plated on
CSM -Trp -Leu plates to select for the transformants. After 3 to 4 days growth on
CSM minus medium, the colonies were replica plated to 5-FOA plates.
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Approximately 11, 100 colonies were screened; 72 colonies were 5-FOA
resistant. To confirm these colonies were 5-FOA resistant, they were restreaked
on 5-FOA plates and tested for their ability to generate single colonies.
To determine whether 5-FOA resistance was due to the transformed rat
brain cDNAplasmid, each·of the 72 colonies was-inoculated into CSM -Trp
+Leu liquid medium to be cured of the mammalian cDNA plasmid. The cells
were then tested for the ability to grow on CSM -uracil plates. If the cells
remained 5-FOA resistant in the absence of the rat brain cDNA plasmid, i.e.,
unable to grow on CSM -uracil medium, then the 5-FOA resistance phenotype
was not due to the interaction of a factor encoded by rat brain cDNA with the
CRS or INS element. If the cells became 5-FOA sensitive in the absence of the
rat brain cDNA plasmid, i.e., capable of growing on CSM -Ura medium, the
'

factor encoded by rat brain cDNA was able to interact with either CRS or INS
element and inhibited the expression of URA3 gene. Unfortunately, 5-FOA
resistance did not correlate with the presence of the rat brain cDNA library
plasmid in any of the 72 colonies.

2. HIV TAR Binding Protein

We also attempted to clone HIV TAR interacting protein factor(s). The
70-bp TAR fragment (with Pstl site engineered in both ends) was constructed
by PCR of two overlapping oligos. The resulting PCR fragment was digested
with Pstl and inserted into the pBluescript vector. The 70-bp Pstl-Pstl fragment
was then cloned into pB10, -30-bp upstream of the URA3 start codon,
producing plasmid pB5-TAR. When JM43 strain was transformed with p85-TAR
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was transformed into JM43, 5-FOA resistance phenotype was conferred.
Transform ants containing the parent plasm id pB 1O did not have this phenotype.
This indicates that the presence of HIV TAR alone inhibits URA3 gene
expression. It is likely that TAR, a stable stem loop motif in the 5' UTA of URA3,
impeded scanning of the 40s initiation complex.

C.

DISCUSSION

Yeast has become an extremely popular and successful model system
for understanding eukaryotic biology. The intracellular organization of these
single cell eukaryotes is much like the cells of more complex organisms.
Conservation is substantial for many basic biologic properties: cytoskeletal
organization, subcellular organelles, secretion, receptor and second
messenger systems, metabolic regulation, and chromosome mechanics. The
exchangebility of proteins of analogous function in yeast and humans has been
demonstrated in several cases. For example, mammalian ras genes
complement yeast ras mutants and vice versa. Human CDC2 gene was cloned
by complementation of a cdc2 mutation in S. pombe. Since human genes
cannot be directly cloned by simple complementation in mammalian systems,
new human genes are often cloned by their complementation of yeast
mutations. In addition, yeast may also serve as the host in which viral
(eg. HIV-1) and human DNA sequences are brought together via yeast vectors.
In the first part of this study, we took a genetic approach to clone
mammalian protein factor(s) that interact with HIV CRS or INS-1 elements.
Unfortunately, all the 5-FOA resistant yeast colonies identified were false
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positives, presumably due to background growth of wild- type cells. This was
demonstrated by the persistence of 5-FOA resistance phenotype even after the
loss of mammalian cDNA plasmids. Our failure to identify a mammalian cDNA
encoded protein factor that interacts with either CRS or INS-1 RNA sequences
could be due to the requirement for more than one factor to efficiently sequester
in the nucleus the transcripts carrying CRS or INS-1. If this is the case, we
would never recover them since only one plasmid is transformed into yeast at a
time. Alternatively, despite much conservation between yeast and human
protein functions, there may be no yeast analogues of HIV-1 CRS and INS-1
RNA-binding proteins. Previous work demonstrating the function of the HIV
CRS or INS-1 was undertaken only in mammalian systems.
In the second part of our study, we attempted to develop a method for
cloning protein factor(s) that interact with an RNA fragment of interest. Our
hypothesis was that translation initiation could be blocked by an RNA/protein
complex in the 5' UTR. However, our result with HIV TAR suggested that URA3
gene expression was inhibited by TAR itself, before transformation of the yeast
with a mammalian cDNA library (containing the putative binding protein). There
are two explanations for this result. First, yeast could have a factor that binds to
HIV TAR. The unknown yeast factor could be a homologue of a mammalian
factor whose binding with HIV TAR is biological significant for HIV life cycle.
Alternatively, the yeast factor may bind to TAR RNA, but without any biological
relevance. Second, the TAR stem loop secondary structure by itself blocked
translation initiation. It is possible that TAR, with its stable stem loop secondary
structure, could not be unwound by the translational machinery. TAR by itself
sterically hindered scanning of the 408 initiation complex and inhibited
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translation initiation. If this is true, our approach to clone RNA interacting factors
could work with RNAs that have weaker secondary structure than HIV TAR.

D. MATERIALS AND METHODS

1. Yeast Strain

JM43 (Mat leu2-3, 112 ura3-52 trp1-289 his4-580) was kindly provided
by Joan mcEwen.

2. Growth Media

YPD, CSM minus mediua are prepared as described in section 3.A.2.
5-FOA plates were made according to the methods of Treco & Lundblad (1993).
1g of 5-FOA powder, 500 ml dH 2 0, 5 ml 2.4 mg/ml uracil solution were mixed
and stirred with low heat -1 hour until completely dissolved. The mixture was
filter sterilized. 1.7 g YNB-AA/AS, 5 g (NH 4)2 , 20 g dextrose, 20 g agar, and
1.3 g uracil dropout premix were mixed in H20 to a final velum of 500 ml. The
mixture was autoclaved. When the molten agar cools to -65°C, the sterile
5-FOA/uracil solution was gently added to the uracil dropout medium by pouring
it down the inside wall of the flask containing the latter. The mixture was swirled
gently to mix and poured into the plates.
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3. Recombinant Plasmids

INS-1 was derived from pBKBH10S (containing HIV proviral DNA except
LTR) by polymerase chain reaction. It was subsequently cloned into Pst1 site in
pBluescript vector. The Pst1 flanking-INS-1 fragment was then cloned
'30 bp downstream of URA3 termination codon in p810 to result in p810-INS.
p810 is derived from cloning yeast Trp1 into multiple cloning sites of PRS416. It
therefore allowed two selections for yeast transformants, on CSM -Trp and on
CSM -Ura.

4. Yeast Transformation

Please refer to section 2.8.3.

5. Northern Blot Analysis

Please refer to section 2.8.8.

E. REFERENCES
Bannerjee AK. 1980. 5'-Terminal cap structure in eucaryotic messenger
ribonucleic acids. Microbiol. Rev. 44: 175-205.
Caughmann SW, Hentze MW, Rouault TA, Harford JB, Klausner RD. 1988. The
iron-responsive element is the single element responsible for irondependent translational regulation of ferritin biosynthesis. Evidence for
function as the binding site for a translational repressor. J. Biol. Chem.
263: 19048-19052.

132
Cullen B, Greene W. 1989. Regulatory pathways governing HIV-1 replication.
Cell 58:423-426.
Chang DD, Sharp PA. 1989. Regulation by HIV Rev depends upon recognition
of splice sites. Cell 59:789-795.
Cochrane AW, Jones KS, Beidas S, Dillon PJ, Skalka AM, Rosen CA. 1991.
lndentification and characterization of intragenic sequences which
repress human immunodeficiency virus structural gene expression.
Journal of Virology 65:5305-5313.
Colicelli J, Birchmeier C, Michaeli T, O'Neill K, Riggs M, Wigler M. 1989.
Isolation and characterization of a mammalian gene encoding a highaffinity cAMP phosphodiesterase. Proc. Natl. Acad. Sci. USA 86:35993603.
Dingwall C, Ernberg I, Gait MJ, Green SM, Heaphy S, Karn J, Lowe AD, Singh
M, Skinner MA, Vallario R. 1989. Human immunodeficiency virus 1 tat
protein binds trans-activation responsive region {TAR) RNA in vitro. Proc.
Natl. Acak. Sci. USA 86:6925-6929.
Emerman M, Vazeux R, Peden K. 1989. The rev gene product of the human
immunodeficiency virus affects envelop-specific RNA localization. Cell
57:1155-1165.
Feng S, Holland EC. 1988. HIV-1 tat trans-activation requires the loop
sequence within TAR. Science 334:165-167.
Hadzopoulou-Cladaras M, Felber BK, Cladaras C, Athanassopoulos A, Tse A,
Pavlakis. 1989. The rev protein of human immunodeficiency virus type 1
affects viral mRNA and protein expression via a cis-acting sequence in
the env region. J. Virol. 63:1265-1274.
Hammarskjold ML, Heimer J, Hammarskjold B, Sangwan I, Albert L, Rekosh D.
1989. Regulation of human immunodeficiency virus env expression by
the rev gene product. J. Virol. 63:1959-1966.
Haile DJ, Hentze MW, Rouault TA, Harford JB, Klausner RD. 1989. Regulation
of interaction of the iron-responsive element binding protein with ironresponsive RNA elements. Mol. Cell. Biol. 9:5055-5061.
Hentze MW, Caughmann SW, Rouault TA, Barriocanal JG, Dancis A, Harford
JB, Klausner RD. 1987a. Identification of the iron-responsive element for
the translational regulation of human ferritin mRNA. Science 238: 15701573.

133
Hentze MW, Rouault TA, Caughmann SW, Dancis A, Harford JB, Klausner RD.
1987b. A cis-acting element is necessary and sufficient for translational
regulation of human ferritin expression in response to iron. Proc. Natl.
Acad. Sci. USA 84:6730-6734.
Jagus R, Anderson WF, Safer B. 1981. The regulation of initiation of mammalian
protein synthesis. Prog. Nucleic acid Res. Mol. Biol. 25: 127-185.
Malim MH, Hauber J, Le SY, Maizel JV, Cullen BR. 1989. The HIV-1 rev
transactivator acts through a structured target sequence to activate
nuckear export of unspliced viral mRNA. Nature 338:254-257.
Muesing MA, Smith DH, Cabradilla CD, Benton CV, Lasky LA, Capon DJ. 1985.
Nucleic acid structure and expression of the human
AIDS/lymphadenopathy retrovirus. Nature 313:450-458.
Muesing MA, Smith DH, Capon DJ. 1987. Regulation of mRNA accumulation by
a human immunodeficiency virus trans-activator protein. Cell 48:691701.
Olsen HS, Cochrane AW, Rosen C. 1992. Interaction of cellular factors with
intragenic cis-acting repressive sequences within the HIV genome.
Virology 191:709-715.
Pavlakis GN, Felber BK. 1990. Regulation of expression of human
immunodefiency virus. New Biol. 2:20-31.
Rosen CA, Pavlakis GN. 1990. Tat and Rev: positive regulators of HIV gene
expression. AIDS 4:499-509.
Rosen CA, Sodroski JG, Haseltine WA. 1985. The location of cis-acting
regulatory sequences in the human T cell lymphotropic virus type Ill
(HTLV-111/LAV) long terminal repeat. Cell 41:813-823.

134
Rosen CA, Terwilliger E, Dayton A, Sodroski JG, Haseltine WA 1988. lntragenic
cis-acting art gene-responsive sequences of the human
imminodeficiency virus. Proc. Natl. Acad. Sci. USA 85:2071-2075.
Rouault T, Hentze MW, Caughmann SW, Harford JB, Klausner RD. 1988.
Binding of a cytosolic protein to the iron-responsive element of human
ferritin messenger RNA Science 241: 1207-1210.
Roy S, Delling U, Chen CH, Rosen CA, Sonerberg N. 1990. A bulge structure in
HIV-1 TAR RNA is required for Tat binding and Tat-mediated transactivation. Genes Dev 4:1365-1373.
Roy S, Parkin NT, Rosen CA, ltovitch J, Sonerberg N. 1990. Structural
requirements for trans activation of human immunodeficiency virus type 1
long terminal repeat-directed gene expression by tat: importance of base
pairing, loop sequence, and bulges in the tat-responsive sequence. J.
Virol. 64: 1402-1406.
Schwartz S, Felber BK, Fenyo EM, Pavlakis GN. 1990. Env and Vpu proteins of
human immunodeficiency virus type 1 are produced from multiple
bicistronic mRNAs. J. Vlrol. 64:5448-5456.
Schwartz S, Felber BK, Pavlakis GN. 1992. Distinct RNA sequences in the gag
region of human immunodeficiency virus type 1 decrease RNA stability
and inhibit expression in the absence of Rev protein. Journal of Virology
66: 150-159.
Sonenberg N, 1988. Cap binding proteins of eukaryotic messenger RNA:
functions in initiation and control of translation. Prog. Nucleic Acids Res.
9: 1643-1656.
Stripecke R and Hentze MW. 1992. Bacteriophage and spliceosomal proteins
function as position-dependent cis/trans repressors of mRNA translation
in vitro. Nuclei Acids Res. 20:5555-5564.
Treco DA, Lundblad V. 1993. Preparation of yeast media. In: Current protocols
in Molecular Biology edited by Ausubel FM, Brent R, Kingston RE, Moore
DD, Seidman JG, Smith JA and Struhl K. New York: Greene Publishing
Associates and Wiley-lnterscience. pp. 13.11.1-13.11.3.

CHAPTER 7
REFERENCES

Abelson J. 1979. RNA processing and the intervening sequence problem. Ann.
Rev. Biochem. 48: 1035-1069.
Abramson RD, Dever TE, Lawson TG, Ray BK, Thach RE, Merrick WC. 1987.
The ATP-dependent interaction of eukaryotic initiation factors with RNA. J
Biol Chem 262:3826-3832.
Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. 1990. Basic local
alignment search tool. J Mo/ Biol 215 :403-410.
Baserga SJ, Steitz JA. 1993. The diverse world of small ribonucleoproteins. In:
Gesteland RF, Atkins JF, eds. The RNA world. Plainview, New York: Cold
Spring Harbor Laboratory Press. pp 359-381.
Berget SM, Moore C, Sharp PA. 1977. Spliced segments at the 5' terminus of
adenovirus 2 late mRNA. Proc Natl Acad Sci USA 74:3171-3175.
Breathnach R, Benoest C, O'hare K, Gannon F, Chambon P. 1978. Ovalbumin
gene: Evidence for a leader sequence in mRNA and DNA sequences at
the exon-intron boundaries. Proc Natl Acad Sci USA 75:4853-4857.
Breeden L, Nasmyth K. 1985. Cold Spring Harbor Symposia on Quantitave
Biology 50 :643-650.
Brody E, Marie J. 1991. RNA secondary structure repression of a musclespecific exon in HeLa cell nuclear extracts. Science 252 : 1823-1828.
Brosi R, groning K, Behrens S-E, Luhrmann R, Kramer A. 1993. Interaction of
mammalian splicing factor SF3a with U2 snRNP and relation of its 60-kD
subunit to yeast PRP9. Science 262:102-105.
Brow D, Guthrie C. 1988. Spliceosomal RNA U6 is remarkably conserved from
yeast to mammals. Nature 334:213-218.
Burgess S, Couto JR, Christine G. 1990. A putative ATP binding protein
influences the fidelity of branchpoint recognition in yeast splicing. Cell
60:705-717.

135

136
Burgess SM, Guthrie C. 1993. A mechanism to enhance mRNA splicing fidelity:
the RNA-dependent ATPase Prp16 governs usage of a discard pathway
for aberrant lariat intermediates. Ce/173 :1377-1391.
Chanfreau G, Legrain P, Dujon B, Jacquier A. 1994. Interactions between the
first and last nucleotides of pre-mRNA intrans is a determinant of 3 1 splice
site selection in S. cerevisiae. Nucleic Acids Res 22: 1981-1987.
Cheng SC, Abelson J. 1987. Spliceosome assembly in yeast. Genes & Dev
1: 1014-1027.
Clouet d'Orval B, D'Aubenton-Carafa Y, Sirand-Pugnet P, Gallego M, Davis LG,
Dibner MD, Battey JF. 1986. Formaldehyde gel for electrophoretic
separation of RNA and Northern blot, pp. 143-146 in Basic methods in
molecular biology. New York: Elsevier Science Publishing Co., Inc.
Company M, Arenas J, Abelson J. 1991. Requirement of the RNA helicase-like
protein PRP22 for release of messenger RNA from spliceosomes. Nature
349: 487-493.
Couto JR, Tamm J, Parker R, Guthrie C. 1987. A trans-acting suppressor
restores splicing of a yeast intron with a branch point mutation. Genes &
Dev 1:445-455.
Crispino JD, Sharp PA. 1995. A U6 snRNA: pre-mRNA interaction can be ratelimiting for U1-independent splicing. Genes & Dev 9:2314-2323.
Dahlberg JE, Lund E. 1988. The genes and transcription of the major small
nuclear RNAs. In Small nuclear ribonucleoprotein particles. ed. M. L.
Birnstiel, pp. 38-70. Springer-Verlag, Berlin.
Deshler JO, Rossi JJ. 1991. Unexpected point mutations activate cryptic 3'
splice sites by perturbing a natural secondary structure within a yeast
intron. Genes & Dev 5 :1252-1263.
Domdey H, Apostol B, Lin RJ, Newman A, Brody E, Abelson J. 1984. Lariat
structures are in vivo intermediates in yeast pre-mRNA splicing. Cell 39:
611-621.
Dom in ski Z, Kole R. 1994. Identification and characterization by anti sense
oligonucleotides of exon and intron sequences required for splicing. Mo/
Cell Biol 14:7445-7454.
Eng FJ, Warner JR. 1991. Structural basis for the regulation of splicing of a
yeast messenger RNA. Ce/165 :797-804.

137
Eperon LP, Graham IR, Griffiths AD. 1988. Effects of RNA secondary structure
on alternative splicing of pre-mRNA: Is folding limited to a region behind
the transcribing RNA polymerase? Ce/154 :393-401.
Field DJ, Friesen JD. 1996. Functionally redundant interactions between U2
and U6 spliceosomal snRNAs. Genes & Dev 10:489-501.
Flint J. 1983. RNA splicing in vitro. In Enzymes of Nucleic Acid Synthesis and
Modification, ed. S. T. Jacob, 2:76-110. Broca Raton, Fla: CRC
Frank D, Guthrie C. 1992. An essential splicing factor, SLU7, mediates 3' splice
site choice in yeast. Genes & Dev 6 :2112-2124.
Fouser LA, Friesen JD. 1986. Mutations in a yeast intron demonstrate the
importance of specific conserved nucleotides for the two stages of
nuclear mRNA splicing. Ce/145: 81-93.
Fuller-Pace FV. 1994. RNA helicases: modulators of RNA structure. Trends Cell
Biol 4:271-27 4.
Gallwitz D. 1982. Construction of a yeast actin gene intron deletion mutant that
is defective in splicing and leads to the accumulation of precursor RNA in
transformed yeast cells. Proc Natl Acad Sci USA 79:3493-3497.
Gillespie DE, Berg CA. 1995. homeless is required for RNA localization in
Drosophila oogenesis and encodes a new member of the DE-H family of
RNA-dependent ATPases. Genes & Dev 9:2495-2508.
Goguel V, Wang Y, Rosbash M. 1993. Short artificial hairpins sequester splicing
signals and inhibit yeast pre-mRNA splicing. Mo/ Cell Biol 13 :68416848.
Goodall GJ, Filipowicz W. 1991. Different effects of intron nucleotide
composition and secondary structure on pre-mRNA splicing in moncot
and dicot plants. EMBO J 1O :2635-2644.
Gorbalenya AE, Koonin EV, Donchenko AP, Blinov VM. 1988. A conserved
NTP-motif in putative helicases. Nature 33 :22.
Gorbalenya AE, Koonin EV, Donchenko AP, Blinov VM. 1989. Two related
superfamilies of putative helicases involved in replication, recombination,
repair and expression of DNA and RNA genomes. Nucleic Acids Res 17
:4713-4730.

138
Grabowski PJ, Padgett RA, Sharp PA. 1984. Messenger RNA splicing in vitro:
an excised intervening sequence and a potential intermediate. Ce// 37:
415-427.
Green MR. 1986. Pre-mRNA splicing. Ann.Rev. Genet 20:671-708.
Grifo JA, Abramson RP, Salter CA, Merrick WC. 1984. RNA stimulates ATPase
activity of eukaryotic initiation factors. J Biol Chem 259 :8648-8654.
Gururajan R, Mathews L, Longo FJ, Weeks DL. 1994. An3 mRNA encodes an
RNA helicase that colocalizes with nucleoli in Xenopus oocytes in a
stage-specific manner. Proc. Natl. Acad. Sci. USA 91:2056-2060.
Guthrie C. 1991. Messenger RNA splicing in yeast: clues to why the
spliceosome is a ribonucleoprotein. Science 253: 157-163.
Guthrie C, Patterson B. 1988. Spliceosomal snRNAs. Annu Rev Genet 22:387419.
Hartwell LH. 1967. Macromolecule synthesis in temperature-sensitive mutants
of yeast. J Bacteriol 93: 1662-1670.
Hashimoto C, Steitz JA. 1984. U4 and U6 RNAs coexist in a single small
nuclear ribonucleoprotein particle. Nucleic Acids Res 12:3283-3293.
Hernandez N, Keller W. 1983. Splicing of in votro synthesized messenger RNA
precursors in Hela cell extracts. Cell 35:89-99.
Hill J, Donald LJ, Griffiths DE. 1991. DMSO-enhanced whole cell yeast
transformation. Nucleic Acids Res 19:5791.
Hirling H, Schaffner M, Restle T, Stahl H. 1989. RNA helicase activity
associated with the human p68 protein. Nature 339:562-564.
Hoeffler JP, Meyer TE, Yun Y, Jameson JL, Habener JF. 1988. Cyclic AMPresponsive DNA binding protein: structure based on a cloned placental
cDNA. Science 242 : 1430-1433.
lost I, Dreyfus M. 1994. mRNAs can be stabilized by DEAD-box proteins. Nature
372: 193-196.
Kassavetis GA, Butler ET, Roulland D, Chamberlin MJ. 1982. Bacteriophage
SP6-specific RNA polymerase: mapping of SP6 DNA and selective in
intro transcription. J. Biol. Chem 257:5779-5788.

139
Kim SH, Lin RJ. 1993. Pre-mRNA splicing within an assembled yeast
spliceosome requires an RNA-dependent ATPase and ATP hydrolysis.
Proc Natl Acad Sci USA 90:888-892.
Kim SH, Smith J, Claude A, Lin RJ. 1992. The purified yeast pre-mRNA splicing
factor PRP2 is an RNA-dependent NTPase. EMBO J 11:2319-2326.
King DS, Beggs JD. 1990. Interactions of PRP2 protein with pre-mRNA splicing
complexes in Saccharomyces cerevisiae. Nucleic Acids Res 18:65596564.
Kole R, Weissman SM. 1982. Accurate in vitro splicing of human B-globin RNA.
Nucleic Acids Res 10:5429-5445.
Konarska MM, Grabowski RA, Padgett RA, Sharp PA. 1985. Characterization of
the branch site in lariat RNAs produced by splicing of mRNA precursors.
Nature 313: 552-557.
Konarska MM, Sharp PA. 1986. Electrophoretic separation of complexes
involved in the splicing of precursors to mRNAs. Cell 46:845-855.
Konarska MM, Sharp PA. 1987. Interactions between small nuclear
ribonucleoprotein particles in formation of spliceosomes. Cell 49:763774.
Konforti BB, Koziolkiewicz MJ, Konarska MM. 1993. Disruption of base pairing
between the 5 1 splice site and the 5' end of U1 snRNA is required for
spliceosomal assembly. Cell 75:863-874.
Konforti BB, Konarska MM. 1994. U4/U5/U6 snRNP recognizes the 5' splice site
in the absence of U2 snRNP. Genes & Dev 8:1962-1973.
Krainer AR, Maniatis T, Ruskin B, Green MR. 1984. Normal and mutant human
B-globin pre-mRNAs are faithflly and efficiently spliced in vitro. Cell
36:993-1005.
Lamond Al. 1991. Nuclear RNA processing. Curr. Opin. Cell Biol. 3:493-501.
Lamond Al, Konarska MM, Grabowski PJ, Sharp PA. 1988. Spliceosome
assembly involves the binding and release of U4 small nuclear
rinonucleoprotein. Proc Natl Acad Sci USA 85:411-415.
Landschulz WH, Johnson PF, McKnight SL. 1988. The DNA binding domain of
the rat liver nuclear protein C/EBP is bipartite. Science 240 :1759-1764.

140
Langford CJ and Gallwitz D. 1983. Evidence for an intron-contained sequence
required for the splicing of yeast RNA polymerase II transcripts. Cell
33:519-527.
Lasko P, Ashburner M. 1988. The product of the Drosophila gene vasa is very
similar to eukaryotic initiation factor-4A. Nature 335 :611-617.
Lauber J, Fabrizio P, Teigelkamp S, Lane WS, Hartmann E, Luhrmann R. 1996.
The Hela 200 KD U5 snRNP-specific protein and its homologue in
Saccharomyces cerevisiae are members of the DEXH-box protein family
of putative RNA helicases. EMBO J 15:4001-4015.
Lerner MR, Boyle JA, Mount SM, Wolin SL, Steitz JA. 1980. Are snRNPs
involved in splicing? Nature 283:220-224.
Libri D, Piseri A, Fiszman MY. 1991. Tissue-specific splicing in vivo of the Btropomyosin gene: dependence on an RNA secondary structure. Science
252: 1842-1845.
Lin J, Rossi JJ. 1996. Identification and characterization of yeast mutants that
overcome an experimentally introduced block to splicing at the 3' splice
site. RNA 2:835-848.
Lin RJ, Lustig AJ, Abelson J. 1987. Splicing of yeast nuclear pre-mRNA in vitro
requires a functional 40S spliceosome and several extrinsic factors.
Genes Dev 1:7-18
Lin RJ, Newman AJ, Cheng SC, Abelson J. 1985. Yeast mRNA splicing in vitro.
J Biol Chem 260: 14780-14792.
Linder P, Lasko PF, Ashburner M, Leroy P, Nielsen PJ, Nishi K, Schnier J,
Slonimski PP. Birth of the D-E-A-D box. 1989. Nature 337 :121-122.
Liu HX, Goodall GJ, Kole R, Filipowicz W. 1995. Effects of secondary structure
on pre-mRNA splicing: hairpins sequestering the 5' but not the 3' splice
site inhibit intron processing in Nicotiana plumbaginifolia. EMBO J 14
:377-388.
Madhani HD, Guthrie C. 1992. A novel base-pairing interaction between U2
and U6 snRNAs suggests a mechanism for the catalytic activation of the
spliceosome. Cell 71:803-817.
Madhani HD, Guthrie C. 1994a. Randomization-selection analysis of snRNAs in
vivo: evidence for a tertiary interaction in the spliceosome. Genes & Dev
8:1071-1081.

141
Madhani HD, Guthrie C. 1994b. Dynamic RNA-RNA interactions in the
spliceosome. Annu. Rev. Genet. 28: 1-26.
Madhani HD, Bordonne R, Guthrie C. 1990. Multiple roles for U6 snRNA in the
splicing pathway. Genes & Dev 4:2264-2277.
Moore MJ, Query CC, Sharp AP. 1993. Splicing of precursors to mRNA by the
spliceosome. In: Gesteland RF, Atkins JF, eds. The RNA world. Plainview,
New York: Cold Spring Harbor Laboratory Press. pp 303-356.
Moore MJ, Sharp AP. 1993. Evidence for two active sites in the splicesome
provided by stereochemistry of pre-mRNA splicing. Nature 365: 364-368.
Mount SM. 1982. A catalogue of splice junction sequences. Nucleic Acids Res
10: 459-472.
Mount SM, Petterson I, Hinterberger M, Karmas A, Steitz JA. 1983. The U1
small nuclear RNA-protein complex selectively binds a 5' splice site in
vitro. Cell 33:509-518.
Newman AJ, Lin RJ, Cheng SC, Abelson J. 1985. Molecular consequences of
specific intron mutations on yeast mRNA splicing in vivo and in vitro. Cell
42:335-344.
Newman AJ, Norman C. 1991. Mutations in yeast U5 snRNA alter the specificity
of 5' splice site cleavage. Cell 65:115-123.
Newman AJ, Norman C. 1992. U5 snRNA interacts with exon sequences at 5'
and 3' splice sites. Cell 68 :743-754.
Newman AJ, Teigelkamp S, Beggs JD. 1995. snRNA interactions at 5' and 3'
splice sites monitored by photoactivated crosslinking in yeast
spliceosomes. RNA 1: 968-980.
Nilsen TW. RNA-RNA interactions in the spliceosome: unraveling the ties that
bind. Cell 78: 1-4.
Nishi K, Morel-Deville F, Hershey JW, Leighton T, Schnier J. An elF-4A-like
protein is a suppressor of an Escherichia coli mutant defective in SOS
ribosomal subunit assembly. 1988. Nature 336 :496-498, and correction.
Nature 340 :246.
Noble SM, Guthrie C. 1996. Identification of novel genes required for yeast premRNA splicing by means of cold-sensitive mutations. Genetics 143:6780.

142
Ohno Y, Ohno M, Shimura Y. 1994. Identification of a putative RNA helicase
(HRH1), a human homolog of yeast Prp22. Mo/ Cell Biol 14:7611-7620.
Orr-weaver TL, Szostak JW, Rothstein RJ. 1981. Yeast transformation: a model
system for the study of recombination. Proc Natl Acad Sci USA 78 :63546358.
O'Shea EK, Rutkowski R, Kim-PS. 1989. Preferential heterodimer formation by
isolated leucine zippers from fos and jun. Science 243· :538-542.
Padgett RA, Mount SM, Steitz JA, Sharp PA. 1983. Splicing of messenger RNA
recursors is inhibited by antisera to small nuclear ribonucleoprotein. Cell
35: 101-107.
Padgett RA, Konarska MM, Grabowski PJ, Hardy SF, Sharp PA. 1984. Lariat
RNAs as intermediates and products in the splicing of messenger RNA
precursors. Science 225: 898-903.
Parker R, Guthrie C. 1985. A point mutation in the conserved hexanucleotide at
a yeast 5 1 splice junction uncouples recognition, cleavage, and ligation.
Cell 41: 107-118.
Parker R, Siliciano PG. 1993. Evidence for an essential non-Watson-Crick
interaction between the first and last nucleotides of a nuclear pre-mRNA
intron. Nature 361:660-662.
Parker R, Siliciano PG, Guthrie C. 1987. Recognition of the TACTAAC box
during mRNA splicing in yeast involves base pairing to the U2-like
snRNA. Cell 49:229-239.
Patterson B, Guthrie C. 1987. An essential yeast snRNA with a US-like domain
is required for splicing in vivo. Cell 49:613-624.
Pause A, Sonenberg N. 1992. Mutational analysis of a DEAD box RNA
helicase: the mammalian translation initiation factor elF-4A. EMBO J.
11:2643-2654.
Pause A, Methot N, Sonenberg N. 1993. The HRIGRXXR region of the DEAD
box RNA helicase eukaryotic translation initiation factor 4A is required for
RNA binding and ATP hydrolysis. Mot Cell Biol 13:6789-6798.
Pikielny CW, Teem JL, Rosbash M. 1983. Evidence for the biochemical role of
an internal sequence in yeast nuclear mRNA introns: implications for U 1
RNA and metazoan mRNA splicing. Cell 34: 395-403.

143
Query CC, Moore MJ, Sharp PA. 1994. Branch nucleophile selection in premRNA splicing: Evidence for the bulged duplex model. Genes & Dev
8:587-597.
Reddy R, Busch H. 1988. Small nuclear RNAs: RNA sequences, structure and
modifications. In: Bimstiel ML, ed. Small nuclear ribonucleoprotein
particles. Springer-Verlag, Berlin. pp 1-37.
Reed R. 1989. The organization of 3' splice site sequences in mammalian
intrans. Genes & Dev 3:2113-2123.
Reich Cl, VanHoy RW, Porter GL, Wise JA. 1992. Mutations at the 3' splice site
can be suppressed by compensatory base changes in U1 snRNA in
fission yeast. Cell 69: 1159-1169.
Reynolds A, Lundblad V. 1993. Yeast vectors and assays for expression of
cloned genes. In: Current protocols in Molecular Biology edited by
Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA
and Struhl K. New York: Greene Publishing Associates and Wileylnterscience. pp. 13.6.1-13.6.4.
Rinke J, Appel B, Digweed M, Luhrmann R. 1985. Localization of a base-paired
interaction between small nuclear RNAs U4 and U6 in intact U4/U6
ribonucleoprotein particles by psoralen cross-linking. J Mo/ Biol 185:721731.
Rogers J, Wall R. 1980. A mechanism for RNA splicing. Proc. Natl. Acad. Sci.
USA 77: 1877-1879.
Rozen F, Edery I, Meerovitch K, Dever TE, Merrick WC, Sonenberg N. 1990.
Birectional RNA helicase activity of eucaryotic translation initiation factors
4A and 4F. Mo/ Cell Biol 10: 1134-1144.
Rozen F, Pelletier J, Trachsel H, Sonenberg N. 1989. A lysine substitution in the
ATP-binding site of eucaryotic initiation factor 4A abrogates nucleotidebinding activity. Mo/ Cell Biol 9 :4061-4063.
Ruby SW, Abelson J. 1991. Pre-mRNA splicing in yeast. Trends Genet 7: 79-85.
Ruby SW, Chang TH, Abelson J. 1993. Four yeast spliceosomal proteins
(PRP5, PRP9, PRP11 and PRP21) interact to promote U2 snRNP binding
to pre-mRNA. Genes & Dev 7:1909-1925.
Ruskin B, Krainer AR, Maniatis T, Green MR. 1984. Excision of an intact intron
as a novel lariat structure during pre-mRNA splicing in vitro. Cell 38: 317331.

144
Ruskin B, Zamore PD, Green MR. 1988. A factor, U2AF, is required for U2
snRNP binding and splicing complex assembly. Cell 52:207-219.
Aymond BC, Rosbash M. 1985. Cleavage of 5' splice site and lariat formation
are independent of 3' splice site in yeast mRNA splicing. Nature 317:735737.
Aymond BC, Rosbash M. 1992. Yeast.pre-mRNA splicing. In: Jones EW, Pringle
JR, Broach JR, eds. The molecular and cellular biology of the yeast
Saccharomyces. Plainview, New York: Cold Spring Harbor Laboratory
Press. pp 143-192.
Santen VL, Spritz LV. 1985. mRNA precursor splicing in vivo: sequence
requirements determined by deletion analysis of an intervening
sequence. Proc Natl Acad Sci USA 82:2885-2889.
Santiago TC, Purvis IJ, Bettany AJE, Brown AJP. 1986. The relationship
between mRNA stability and length in Saccharomyces cerevisiae.
Nucleic Acids Res 14:8347-8360.
Saraste M, Sibbald PR, Wittinghofer A. 1990. The P-loop: a common motif in
ATP- and GTP-binding proteins. Trends Biochem Sci 15:430-434.
Sawa H, Ohno M, Sakamoto H, Shimura Y. 1988. Requirement of ATP in the
second step of the pre-mRNA splicing reaction. Nucleic Acids Res
16:3157-3164.
Schmid SR, Linder P. 1992. D-E-A-D protein family of putative RNA helicases.
Mo/ Microbiol 6(3) :283-292.
Schwer B, Guthrie C. 1991. PRP16 is an RNA-dependent ATPase that interacts
transiently with the spliceosome. Nature 349:494-499.
Schwer B, Guthrie C. 1992. A conformational rearrangement in the spliceosome
is dependent on PRP16 and ATP hydrolysis. EMBO J 11:5033-5039.
Schwer B, Guthrie C. 1993. A dominant negative mutation in a spliceosomal
ATPase affects ATP hydrolysis but not binding to the spliceosome. Mot.
Cell. Biol 12: 3540-354 7.
Seraph in B, Kretzner L, Rosbash M. 1988. A U 1 snRNA-pre-mRNA base pairing
interaction is required early in spliceosome assembly but does not
uniquely define the 5' splice site. EMBO J 7:2533-2538.
Seraphin B, Rosbash M. 1990. Exon mutations uncouple 5' splice site selection
from U1 snRNA pairing. Cell 63:619-629.

145
Sharp PA. 1987. Splicing of messenger RNA precursors. Science 235: 766771.
Sharp PA. 1994. Split genes and RNA splicing. Cell 77:805-815.
Siliciano PG, Guthrie C. 1988. 5' splice site selection in yeast: Genetic
alterations in base-pairing with U1 reveal additional requirements.
Genes & Dev 2: 1258-1267.
Sikorski RS, Hieter P. 1989. A system of shuttle vectors and yeast host strains
designed for efficient manipulation of DNA in Saccharomyces cerevisiae.
Genetics 122 : 19-27.
Sollner-Webb B, Tye K, Steitz JA. 1993. Ribosomal RNA processing in
eukaryotes. In Ribosomal RNA: Structure, evolution, processing and
function in protein synthesis. CRC Press, Boca Raton, Florida.
Solnick D. 1981. An adenovirus mutant defective in splicing RNA from early
region IA. Nature 291:508-510.
Solnick D. 1985. Alternative splicing caused by RNA secondary structure. Cell
43:667-676.
Sontheimer EJ, Steitz JA. 1993. The U5 and U6 small nuclear RNAs as active
site components of the spliceosome. Science 262 :1989-1996.
Steitz JA, Black DA, Gerke V, Parker KA. 1988. Structure and function of major
and minor small nuclear ribonucleoprotein particles, M. L. Birnstiel, ed.
(New York: Springer-Verlag), pp. 115-154.
Strauss EJ, Guthrie C. 1994. PRP28, a "DEAD-box" protein, is required for the
first step of mRNA splicing in vitro. Nucleic Acids Res 22:3187-3193.
Teem JL, Abovich N, Kaufer NF, Schwindinger WF, Warner JR, Levy A,
Woolford J, Leer RJ, van Raamsdonk-Duin MM, Mager WH, Planta RJ,
Schultz L, Friesen JD, Fried H, Rosbach M. 1984. A comparison of yeast
ribosomal protein gene DNA sequences. Nucleic Acids Res. 12:82958312.
Toone WM, Rudd, KE, Friesen JD.1991. deaD, a new Escherichia coli gene
encoding a presumed ATP-dependent RNA helicase, can suppress a
mutation in RSSB, the gene encoding ribosomal pretein S2. J Bacterial.
173 :3291-3302.

146
Treco DA. 1993. Preparation of yeast DNA, RNA, and proteins. In: Current
protocols in Molecular Biology edited by Ausubel FM, Brent R, Kingston
RE, Moore DD, Seidman JG, Smith JA and Struhl K. New York: Greene
Publishing Associates and Wiley-lnterscience. pp. 13.11.1-13. 11.3.
Treco DA, Winston. 1993. Growth and manipulation of yeast. In: Current
protocols in Molecular Biology edited by Ausubel FM, Brent R, Kingston
RE, Moore DD, Seidman JG, Smith JA and Struhl K New York: .Greene
Publishing Associates and Wiley-lnterscience. pp. 13.2.1-13.2.12.
Treisman R, Orkin SH, Maniatis T. 1983. Specific transcription and RNA splicing
defects in five cloned B-thalassemia genes. Nature 302:591-596.
Umen JG, Guthrie C. 1995a. A novel role for a US snRNP protein in 3' splice site
selection. Genes & Dev 9 :855-868.
Umen JG, Guthrie C. 1995b. The second catalytic step of pre-mRNA splicing.
RNA 1:869-885.
Umen JG, Guthrie C. 1995c. Prp16p, Slu7p, andf Prp8p interact with the 3'
splice site in two distinct stages during the second catalytic step of prem RNA splicing. RNA 1:584-597.
Vijayraghavan U, Parker R, Tamm J, limura Y, Rossi J, Abelson J, Guthrie C.
1986. Mutations in conserved intron sequences affect multiple steps in
the yeast splicing pathway, particularly assembly of the spliceosome.
Embo J 5: 1683-1695.
Walker JE, Saraste M, Runswick MJ, Gay NJ. 1982. Distantly related sequences
in the alpha- and beta- subunits of ATP synthase, myosin, kinases and
other ATP-requiring enzymes and a common nucleotide binding fold.
EMBO J 1 :945-951.
Wassarman DA, Steitz JA. 1991. Alive with DEAD proteins. Nature 349 :463464.
Watakabe A, Inoue K, Sakamoto H, Shimura Y. 1989. A secondary structure at
the 3' splice site affects the in vitro splicing reaction of mouse
immunoglobulin chain pre-mRNAs. Nucleic Acids Res 17 :8159-8169.
Wells SE, Manuel Ares JR. 1994. Interactions between highly conservced U2
small nuclear RNA structures and Prp5p, Prp9p, Prp11p, and Prp21 p
proteins are required to ensure integrity of the U2 small nuclear
ribonucleoprotein in Saccharomyces cerevisiae. Mo/ Cell Biol 14:63376349.

iNIVERSITY LIBRARY

~MA LINDA. CALIFORNIA

147

Wieringa B, Hofer E, Weissmann C. 1984. A minimal intron length but no
specific internal sequence is required for splicing the large rabbit Bglobin intron. Cell 37:915-925.
Winston F. 1993. Mutagenesis of yeast cells. In: Current protocols in Molecular
Biology edited by Ausubel FM, Brent R, Kingston RE, Moore DD,
Seidman JG, Smith JA and Struhl K. New York: Greene Publishing
Associates and Wiley-lnterscience. pp. 13.3.1-13.3.4. .
Wyatt JR, Sontheimer EJ, Steitz JA. 1992. Site-specific cross-linking of
mammalian US snRNP to the 5' splice site before the first step of premRNA splicing. Genes & Dev 6 :2542-2553.
Xu DM, Nouraini S, Field D, Tang SJ, Friesen JD. 1996. An RNA-dependent
ATPase associated with U2/U6 snRNAs in pre-mRNA splicing. Nature
381:709-713.
Yoshimatsu T, Nagawa F. 1989. Control of gene expression by artificial intrans
in Saccharomyces cerevisiae. Science 244 :1346-1348.
Zamore PD, Green MR. 1989. Identification, purification, and biochemical
characterization of U2 small nuclear ribonucleoprotein auxiliary factor.
Proc Natl Acad Sci USA 86:9243-9247.
Zamore PD, Green MR. 1991. Biochemical chareacterization of U2 snRNP
auxiliary factor: An essential pre-mRNA splicing factor with a novel
intranuclear distribution. EMBO J. 10:207-214.
Zhuang Y, Weiner AM. 1986. A compensatory base change in U1 snRNA
suppresses a 5' splice site mutation. Cell 46:827-835.

